<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">98238</article-id><article-id pub-id-type="doi">10.7554/eLife.98238</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.98238.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>A <italic>Ctnnb1</italic> enhancer transcriptionally regulates Wnt signaling dosage to balance homeostasis and tumorigenesis of intestinal epithelia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hua</surname><given-names>Xiaojiao</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0002-3005-9006</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Chen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Jianbo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9493-694X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Junbao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Miao</surname><given-names>Xiaoping</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Gen</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Min</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Liu</surname><given-names>Ying</given-names></name><email>y.liu@whu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhou</surname><given-names>Yan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2713-4442</contrib-id><email>yan.zhou@whu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01v5mqw79</institution-id><institution>Department of Neurosurgery, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/033vjfk17</institution-id><institution>Frontier Science Center of Immunology and Metabolism, Wuhan University</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/033vjfk17</institution-id><institution>Department of Epidemiology and Biostatistics, School of Public Health, Wuhan University</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/033vjfk17</institution-id><institution>TaiKang Center for Life and Medical Sciences, Wuhan University</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00p991c53</institution-id><institution>Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/033vjfk17</institution-id><institution>College of Life Sciences, Wuhan University</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01v5mqw79</institution-id><institution>Department of Gastroenterology, Zhongnan Hospital of Wuhan University</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Palmiter</surname><given-names>Richard D</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>Howard Hughes Medical Institute, University of Washington</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cheah</surname><given-names>Kathryn Song Eng</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02zhqgq86</institution-id><institution>University of Hong Kong</institution></institution-wrap><country>Hong Kong</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>25</day><month>09</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP98238</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-06-20"><day>20</day><month>06</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-06-24"><day>24</day><month>06</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.06.21.600033"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-08-07"><day>07</day><month>08</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.98238.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-09-04"><day>04</day><month>09</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.98238.2"/></event></pub-history><permissions><copyright-statement>© 2024, Hua et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Hua et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-98238-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-98238-figures-v1.pdf"/><abstract><p>The β-catenin-dependent canonical Wnt signaling is pivotal in organ development, tissue homeostasis, and cancer. Here, we identified an upstream enhancer of <italic>Ctnnb1</italic> – the coding gene for β-catenin, named ieCtnnb1 (<italic>i</italic>ntestinal <italic>e</italic>nhancer of <italic>Ctnnb1</italic>), which is crucial for intestinal homeostasis. ieCtnnb1 is predominantly active in the base of small intestinal crypts and throughout the epithelia of large intestine. Knockout of ieCtnnb1 led to a reduction in <italic>Ctnnb1</italic> transcription, compromising the canonical Wnt signaling in intestinal crypts. Single-cell sequencing revealed that ieCtnnb1 knockout altered epithelial compositions and potentially compromised functions of small intestinal crypts. While deletion of ieCtnnb1 hampered epithelial turnovers in physiologic conditions, it prevented occurrence and progression of Wnt/β-catenin-driven colorectal cancers. Human ieCTNNB1 drove reporter gene expression in a pattern highly similar to mouse ieCtnnb1. ieCTNNB1 contains a single-nucleotide polymorphism associated with <italic>CTNNB1</italic> expression levels in human gastrointestinal epithelia. The enhancer activity of ieCTNNB1 in colorectal cancer tissues was stronger than that in adjacent normal tissues. HNF4α and phosphorylated CREB1 were identified as key trans-factors binding to ieCTNNB1 and regulating <italic>CTNNB1</italic> transcription. Together, these findings unveil an enhancer-dependent mechanism controlling the dosage of Wnt signaling and homeostasis in intestinal epithelia.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>canonical Wnt signaling</kwd><kwd>intestinal epithelial homeostasis</kwd><kwd>colorectal cancer</kwd><kwd>enhancer</kwd><kwd>Ctnnb1</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012166</institution-id><institution>National Key Research and Development Program of China</institution></institution-wrap></funding-source><award-id>2022YFA0806603</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Yan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>32270876</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Yan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012166</institution-id><institution>National Key Research and Development Program of China</institution></institution-wrap></funding-source><award-id>2018YFA0800700</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Yan</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31970770</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Yan</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>32470776</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Ying</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012226</institution-id><institution>Fundamental Research Funds for the Central Universities</institution></institution-wrap></funding-source><award-id>2042022dx0003</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Yan</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012226</institution-id><institution>Fundamental Research Funds for the Central Universities</institution></institution-wrap></funding-source><award-id>2042023kf0234</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Yan</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>Hubei Natural Science Foundation</institution></institution-wrap></funding-source><award-id>2022CFB128</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Ying</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>An enhancer-dependent transcriptional machinery finely tunes the expression of <italic>Ctnnb1</italic> in intestinal crypts, thereby balancing homeostasis and tumorigenesis of intestinal epithelia.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The gastrointestinal (GI) epithelium, a high turnover organ, contains multiple cell types to fulfill complex functions including food digestion, nutrient absorption, pathogen insulation, and clearance, as well as endocrine roles (<xref ref-type="bibr" rid="bib48">Noah et al., 2011</xref>; <xref ref-type="bibr" rid="bib12">Chin et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Kurokawa et al., 2020</xref>). Enterocytes (ECs) constitute ~90% of all differentiated cells and function as highly efficient cells for absorbing nutrients and water (<xref ref-type="bibr" rid="bib61">Snoeck et al., 2005</xref>). Goblet cells (GCs) produce mucus to lubricate the mucosal surface (<xref ref-type="bibr" rid="bib23">Gustafsson and Johansson, 2022</xref>). Enteroendocrine cells (EECs) sense luminal nutrients and secrete peptide hormones to regulate appetite, intestinal motility, and insulin release (<xref ref-type="bibr" rid="bib21">Gribble and Reimann, 2019</xref>). Tuft cells (TCs) are chemosensory cells that respond to various stimuli including infections and hypoxia (<xref ref-type="bibr" rid="bib58">Schneider et al., 2019</xref>). The crypts of GI epithelium harbor various types of stem cells that continually replenish lost epithelial cells (<xref ref-type="bibr" rid="bib65">van der Flier and Clevers, 2009</xref>; <xref ref-type="bibr" rid="bib55">Ramadan et al., 2022</xref>). While the prevailing belief is that <italic>Lgr5</italic>-expressing crypt base columnar (CBC) cells are actively dividing stem cells and <italic>Bmi</italic>-expressing ‘+4’ cells (positioned four cells above the base of the crypt) are slowly cycling stem cells, it’s important to note that crypt cells have the capacity for fate reprogramming and de-differentiation to sustain regenerative capability (<xref ref-type="bibr" rid="bib5">Barker et al., 2007</xref>; <xref ref-type="bibr" rid="bib64">Tian et al., 2011</xref>; <xref ref-type="bibr" rid="bib72">Yan et al., 2012</xref>; <xref ref-type="bibr" rid="bib45">Metcalfe et al., 2014</xref>; <xref ref-type="bibr" rid="bib7">Beumer and Clevers, 2016</xref>). Intestinal stem cells generate transit-amplifying cells (TACs), which undergo multiple cell divisions and differentiate into all intestinal lineages while migrating toward the crypt orifice (<xref ref-type="bibr" rid="bib30">Krausova and Korinek, 2014</xref>). In addition to stem and progenitor cells, the base of small intestinal crypts contains Paneth cells (PCs) that secret antimicrobial peptides, called defensins, thereby contributing to host defense against microbes (<xref ref-type="bibr" rid="bib40">Lueschow and McElroy, 2020</xref>; <xref ref-type="bibr" rid="bib6">Barreto et al., 2022</xref>). PCs also contribute to the stem cell niche function, e.g., secreting Wnt ligands, to maintain epithelial homeostasis of the small intestine (<xref ref-type="bibr" rid="bib57">Sato et al., 2011</xref>).</p><p>The behavior of crypt cells is precisely regulated by multiple signals, which can act sequentially, additively, synergistically, or antagonistically (<xref ref-type="bibr" rid="bib46">Nakamura et al., 2007</xref>). Among them, the Wnt/β-catenin signal pathway represents the principal force governing intestinal epithelium homeostasis, particularly in the preservation of stem cell proliferation and multipotency (<xref ref-type="bibr" rid="bib53">Pinto et al., 2003</xref>; <xref ref-type="bibr" rid="bib16">Clevers et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Mah et al., 2016</xref>). Upon Wnt ligand binding, the β-catenin degradation complex is inactivated, leading to accumulation of β-catenin and its translocation into the nucleus, where it works with the co-activator TCF7L2 to turn on the transcription of a plethora of target genes, including <italic>MYC</italic>, <italic>CCND1</italic>, <italic>AXIN2</italic>, and <italic>CD44</italic> (<xref ref-type="bibr" rid="bib13">Clevers, 2006</xref>; <xref ref-type="bibr" rid="bib14">Clevers and Nusse, 2012</xref>; <xref ref-type="bibr" rid="bib49">Nusse and Clevers, 2017</xref>). Inhibition of Wnt ligand secretion reduced the number of functional stem cells and led to a faster crypt fixation rate (<xref ref-type="bibr" rid="bib27">Huels et al., 2018</xref>). In the process of aging, reduced Wnt signaling in stem cells and the niche of intestinal crypts causes inhibition of proliferation and reduced numbers of intestinal stem cells (<xref ref-type="bibr" rid="bib47">Nalapareddy et al., 2017</xref>; <xref ref-type="bibr" rid="bib52">Pentinmikko et al., 2019</xref>). The Wnt signal is also essential for commitment, maturation, and location of PCs and other secretory cells (<xref ref-type="bibr" rid="bib66">van Es et al., 2005</xref>; <xref ref-type="bibr" rid="bib1">Andreu et al., 2008</xref>). On the other hand, Wnt, EGF, and Delta-like 1/4 ligands presented by PCs sustained CBCs’ proliferative states and the production (<xref ref-type="bibr" rid="bib57">Sato et al., 2011</xref>). Although the Wnt signal dosage, largely via post-translational regulations, controls early lineage specification, hematopoiesis, and tumorigenesis (<xref ref-type="bibr" rid="bib41">Luis et al., 2011</xref>; <xref ref-type="bibr" rid="bib4">Bakker et al., 2013</xref>), it remains elusive how Wnt signaling dosage, particularly through the transcriptional control of <italic>Ctnnb1</italic> – the coding gene for β-catenin, regulates composition and function of intestinal epithelia.</p><p>Aberrant activation of canonical Wnt signaling is associated with GI cancers, most notably colorectal cancer (CRC) (<xref ref-type="bibr" rid="bib77">Zhao et al., 2022</xref>; <xref ref-type="bibr" rid="bib79">Zhu and Li, 2023</xref>). Germinal mutations of the <italic>APC</italic> gene, which encodes the negative regulator of β-catenin, underlie the familial adenomatous polyposis, a hereditary neoplastic syndrome and the pre-cancerous condition for CRC (<xref ref-type="bibr" rid="bib11">Cheng et al., 2019</xref>; <xref ref-type="bibr" rid="bib35">Li et al., 2021a</xref>). Moreover, <italic>APC</italic> is mutated in up to 80% of human sporadic CRCs (<xref ref-type="bibr" rid="bib36">Li et al., 2021b</xref>). Inactivation of APC causes enhanced accumulation of β-catenin in nuclei and subsequent activation of proliferative and pro-survival signals in CRC cells (<xref ref-type="bibr" rid="bib11">Cheng et al., 2019</xref>). However, largely due to lack of specificity, no molecular therapeutic strategy targeting the pathway has been incorporated into CRC treatment. Interestingly, the transcriptional activity of <italic>CTNNB1</italic>, the coding gene for β-catenin, is also enhanced in CRCs (<xref ref-type="bibr" rid="bib63">Terrin et al., 2017</xref>); however, the underlying mechanism is largely unknown. Dissecting it would facilitate the development of new Wnt/β-catenin targeting means to treat CRC.</p><p>Enhancers are essential <italic>cis</italic>-regulatory DNA elements that control spatiotemporal gene expressions during cell fate specification and maintenance (<xref ref-type="bibr" rid="bib51">Pachano et al., 2022</xref>). Active enhancers are often associated with cell fate specifiers, mostly transcription factors (TFs), and are enriched with specific histone modification such as H3K27ac (acetylated lysine 27 of histone H3) and H3K4me1 (mono-methylated lysine 4) of histone H3 (<xref ref-type="bibr" rid="bib28">Jindal and Farley, 2021</xref>). Importantly, variations of enhancer sequences often lead to aberrant gene silence and activation, thereby causing developmental anomalies and cancers (<xref ref-type="bibr" rid="bib74">Zabidi and Stark, 2016</xref>; <xref ref-type="bibr" rid="bib59">Sengupta and George, 2017</xref>; <xref ref-type="bibr" rid="bib33">Kvon et al., 2021</xref>). Although numerous putative enhancers have been identified by high-throughput studies, only a fraction of them were functionally annotated (<xref ref-type="bibr" rid="bib2">Arnold et al., 2013</xref>; <xref ref-type="bibr" rid="bib37">Li et al., 2021c</xref>; <xref ref-type="bibr" rid="bib73">Yao et al., 2022</xref>).</p><p>The proper expression of essential fate genes in different cell types is often controlled by specific enhancers (<xref ref-type="bibr" rid="bib33">Kvon et al., 2021</xref>; <xref ref-type="bibr" rid="bib51">Pachano et al., 2022</xref>). Here, we have identified an intestinal enhancer for <italic>Ctnnb1</italic> and name it as ieCtnnb1 (<underline>i</underline>ntestinal <underline>e</underline>nhancer of <italic><underline>C</underline>tnnb1</italic>). Reporter mice showed that ieCtnnb1 is predominantly active in the base of small intestinal crypts and across the epithelium of large intestine. Knockout of ieCtnnb1 slows down turnovers of intestinal epithelia at physiology and cancer conditions in a Wnt/β-catenin-dependent manner. The human ieCTNNB1 contains a single-nucleotide polymorphism (SNP) that is associated with <italic>CTNNB1</italic> expression levels in human GI epithelia. The enhancer activity of ieCTNNB1 in CRC tissues is higher than that in adjacent normal tissues and positively correlates with <italic>CTNNB1</italic> expression levels. HNF4α and phosphorylated CREB1 at serine 133 (p-S133-CREB1) were found to associate with ieCtnnb1 and regulate <italic>Ctnnb1</italic> transcription.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>ieCtnnb1 is a GI enhancer of <italic>Ctnnb1</italic></title><p>We previously identified an evolutionarily conserved upstream enhancer for <italic>Ctnnb1</italic> – neCtnnb1, which regulates neocortical neurogenesis (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). We reasoned that there might be other potential enhancer regions that control <italic>Ctnnb1</italic> expression in a cell-specific manner. Therefore, we scanned upstream regions of <italic>Ctnnb1</italic> for active enhancer properties – open chromatin with enriched H3K27ac and H3K4me1 – in different tissues using data retrieved from the ENCODE database. Interestingly, we noticed that a region that is 29,068 base pair (bp) upstream of the transcription starting site for <italic>Ctnnb1</italic> displayed typical enhancer feature in intestinal tissues and resides in the same topologically associating domain (TAD) with <italic>Ctnnb1</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). The region, named as ieCtnnb1 (<underline>i</underline>ntestinal <underline>e</underline>nhancer of <italic>Ctnnb1</italic>), is at open chromatin status (DNase I hypersensitive site) and enriched with H3K27ac and H3K4me1, two histone marks for active enhancers, in 8-week-old mouse small intestine tissue (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Importantly, the enrichment of H3K27ac at ieCtnnb1 is also prominent in embryonic intestine and stomach tissue, as well as in adult kidney and liver (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B and D</xref>). In contrast, the enrichment was not detected in non-GI tissues such as embryonic and adult brain (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). In line with signatures of active enhancers, the enrichment of H3K4me3 and H3K36me3 at ieCtnnb1 is negligible in all examined tissues (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B and C</xref>). Notably, unlike neCtnnb1, the primary sequence of ieCtnnb1 is not conserved among vertebrates (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, bottom).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>ieCtnnb1 is an intestinal enhancer of <italic>Ctnnb1</italic>.</title><p>(<bold>A</bold>) Schematic representation of the upstream region of mouse <italic>Ctnnb1</italic> gene and the location of ieCtnnb1 (6,399 bp, pink shading), which is marked by H3K27ac and H3K4me1 peaks, and DNase I hypersensitivity in small intestine and large intestine of 8-week-old mice. The sequence conservation of the indicated species is shown at the bottom as vertical lines. Data were obtained from ENCODE. Locations of single-guide RNAs (sgRNAs) for generating ieCtnnb1 knockout mice were marked. (<bold>B</bold>) Top left: a schematic illustration showing that the knock-in reporter construct carries the <italic>Shh</italic> promoter, ieCtnnb1 core region sequences (2,153 bp), and the <italic>LacZ</italic> reporter gene. Top right: X-Gal staining (blue) of the gastrointestinal (GI) tract of an 8-week-old <italic>H11<sup>i.enh</sup></italic> mouse. Bottom: X-Gal staining (blue) of the small intestine (left) and colon (right) of an 8-week-old <italic>H11<sup>i.enh</sup></italic> mouse. Boxed areas were enlarged at top-right corners. (<bold>C</bold>) Representative images of small intestinal crypts co-labeled by X-Gal with OLFM4 (left), and X-Gal with Lysozyme (right). (<bold>D–E</bold>) Representative images of whole body (<bold>d</bold>) and GIs (<bold>e</bold>) of 8-week-old male wildtype (WT) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice. (<bold>F</bold>) Comparison of the body weight of 8-week-old male WT (n=13) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=13) mice. (<bold>G–H</bold>) Measurements of small (<bold>G</bold>) and large (<bold>H</bold>) intestine length of 8-week-old male WT (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=6) mice. (<bold>I–J</bold>) Relative mRNA levels of <italic>Ctnnb1</italic> in small (<bold>I</bold>) and large (<bold>J</bold>) intestinal crypts of WT (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=6) mice. (<bold>K–L</bold>) Left: immunoblotting of nuclear (<bold>K</bold>) and cytoplasmic (<bold>L</bold>) β-catenin, GAPDH, and H3 of small intestinal crypts of WT (n=3) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=3) mice. Right: histograms showing protein levels of β-catenin normalized to H3 (<bold>K</bold>) or GAPDH (<bold>L</bold>) levels. Values of WT were set as ‘1’. (<bold>M</bold>) Heatmap of indicated Wnt target genes and gene set enrichment analysis (GSEA) of Wnt signaling pathway according to transcriptome profiles of small intestinal crypts of WT (n=3) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=3) mice. (<bold>N</bold>) Quantitative reverse transcription PCR (RT-qPCR) showing relative mRNA levels of indicated Wnt target genes (<italic>Axin2, Lgr5,</italic> and <italic>Mmp7</italic>) in small intestinal crypts of WT (n=3) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=3) mice. Scale bars, 1 cm (B, top; <bold>D and E</bold>), 100 μm (B, bottom), 10 μm (B, magnified views; <bold>C</bold>). Quantification data are shown as means ± SEM, statistical significance was determined using an unpaired two-tailed Student’s <italic>t</italic>-test (<bold>F–L</bold>). Quantification data are shown as means ± SD, statistical significance was determined using Multiple <italic>t</italic>-tests – one per row (<bold>N</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant. NES: normalized enrichment score.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1">Figure 1F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1">Figure 1G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1">Figure 1H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><label>Figure 1—source data 4.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1">Figure 1I</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata5"><label>Figure 1—source data 5.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1">Figure 1J</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata6"><label>Figure 1—source data 6.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1">Figure 1K</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data6-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata7"><label>Figure 1—source data 7.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1">Figure 1L</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data7-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata8"><label>Figure 1—source data 8.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1">Figure 1N</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data8-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata9"><label>Figure 1—source data 9.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data9-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata10"><label>Figure 1—source data 10.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-data10-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>ieCtnnb1 is a putative intestinal enhancer upstream of <italic>Ctnnb1</italic>.</title><p>(<bold>A</bold>) Schematic representation of the upstream region of mouse <italic>Ctnnb1</italic> gene and locations of enhancer neCtnnb1 (green shading) and putative enhancer ieCtnnb1 (pink shading). Data were obtained from ENCODE. (<bold>B–C</bold>) Enrichment of indicated signals in developing intestine (<bold>B</bold>), stomach, and liver (<bold>C</bold>) were shown. Data were obtained from ENCODE. (<bold>D</bold>) Enrichment of H3K27ac chromatin immunoprecipitation sequencing (ChIP-seq) signals in indicated mouse tissues. Data were obtained from ENCODE.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>ieCtnnb1 is predominantly active in developing intestine.</title><p>(<bold>A</bold>) Hi-C data of BALB/c mouse large intestine at indicated locus. Boundaries of topologically associating domains (TADs) and locations of <italic>Ctnnb1</italic> promoter and ieCtnnb1 (blue bars) were marked. (<bold>B</bold>) Top: schematic representation of ieCtnnb1 core region (2,153 bp, dark purple shading). The location of an annotated ENCODE cCRE was indicated. Bottom: HEK293T, HCT116, and HeLa cells were transfected with indicated plasmids for 48 hr for luciferase reporter assay. (<bold>C</bold>) Representative images showing X-Gal staining of proximal, middle, and distal small intestinal sections of 8-week-old <italic>H11<sup>i.enh</sup></italic> mice (blue). (<bold>D</bold>) Representative image showing X-Gal and eosin staining of the liver of 8-week-old <italic>H11<sup>i.enh</sup></italic> mice (X-Gal: blue, eosin: red). (<bold>E</bold>) Immunoblotting of indicated proteins derived from proximal, middle, and distal small intestine tissues of WT C57/BL6 mice. (<bold>F</bold>) Flow cytometry assays to isolate GFP+ and GFP- cells from small intestinal crypts of <italic>Lgr5</italic>-EGFP (n=3) and <italic>Ctnnb1<sup>Δi.enh</sup>;Lgr5</italic>-EGFP (n=3) mice. Quantitative reverse transcription PCR (RT-qPCR) showing relative mRNA levels of <italic>GFP, Lgr5,</italic> and <italic>LacZ</italic> in aforementioned GFP+ and GFP- cells. (<bold>G–H</bold>) Representative images showing X-Gal staining of gastrointestinal tracts, and sections of proximal and distal small intestine, and large intestine of P7 <italic>H11<sup>i.enh</sup></italic> (<bold>G</bold>) mice and P7 BAT-Gal mice (<bold>H</bold>). (<bold>I</bold>) Generation and genotyping of <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice. WT, wild-type; sgRNA, single-guide RNA. (<bold>J</bold>) Relative mRNA levels of <italic>Ctnnb1</italic> in the liver of WT (n=3) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=3) mice. (<bold>K</bold>) Relative mRNA levels of genes (<italic>Ulk4, Rpl14,</italic> and <italic>Entpd3</italic>) located in the same TAD as <italic>Ctnnb1</italic> in small intestinal crypts of WT (n=3) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=3) mice. Scale bars, 1 cm (whole mount in F and G), 100 μm (<bold>C, D, F, and G</bold>), 10 μm (magnified insets in C). Quantification data are shown as means ± SEM. Statistical significance was determined using two-way ANOVA (<bold>B</bold>) and an unpaired two-tailed Student’s <italic>t</italic>-test (<bold>F, J, and K</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-figsupp2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s2sdata2"><label>Figure 1—figure supplement 2—source data 2.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-figsupp2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s2sdata3"><label>Figure 1—figure supplement 2—source data 3.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2J</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-figsupp2-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s2sdata4"><label>Figure 1—figure supplement 2—source data 4.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2K</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-figsupp2-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s2sdata5"><label>Figure 1—figure supplement 2—source data 5.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-figsupp2-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s2sdata6"><label>Figure 1—figure supplement 2—source data 6.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig1-figsupp2-data6-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>The list of Wnt signaling pathway components downregulated in <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts.</title><p>(<bold>A</bold>) A schematic diagram highlighting downregulated components of the Wnt signaling pathway in the crypts of the <italic>Ctnnb1<sup>Δi.enh</sup></italic> small intestine. (<bold>B</bold>) A table showing Wnt signaling pathway components downregulated in <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig1-figsupp3-v1.tif"/></fig></fig-group><p>We next performed in vitro and in vivo analyses to validate ieCtnnb1’s enhancer activity. First, the 2,153 bp core region (CR), representing the H3K27ac peak region of ieCtnnb1, could drive the expression of luciferase reporter in multiple cell types (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). Second, the ieCtnnb1 reporter mice (<italic>H11<sup>i.enh</sup></italic>) were constructed by inserting the reporter cassette – 5’-<italic>Shh</italic>’s promoter-ieCtnnb1-CR-<italic>LacZ-iCre</italic>-3’ – into the <italic>H11</italic> locus (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Of note, the <italic>Shh</italic> promoter alone at the <italic>H11</italic> locus did not drive the expression of reporter gene in all examined tissue (<xref ref-type="bibr" rid="bib32">Kvon et al., 2020</xref>). Whole-mount β-galactosidase (β-gal) staining of 8-week-old tissues revealed prominent ieCtnnb1-<italic>LacZ</italic> signals along the GI tract. The signal exhibited a proximal-low to distal-high gradient<italic>,</italic> with the ileum, cecum, and colon showing the strongest signals (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>). The stomach and proximal duodenum also displayed reporter activity driven by ieCtnnb1 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>). β-Gal staining of intestinal sections revealed that the ieCtnnb1-<italic>LacZ</italic> signal could be visualized at the bottom of small intestinal crypts and in the entire large intestinal epithelia, but is absent in sections of liver, kidney, and spleen (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D</xref> and data not shown). Interestingly, the proximal-low to distal-high gradient of ieCtnnb1-<italic>LacZ</italic> signal along the small intestine corresponds to the expression pattern of β-catenin (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref>).</p><p>The transcription activity of ieCtnnb1 is strongest at the bottom of crypts, where <italic>Lgr5</italic>-expressing CBC cells and PCs reside. To more precisely elucidate cell types in which ieCtnnb1 is active, we crossed <italic>H11<sup>i.enh</sup></italic> mice with <italic>Lgr5</italic>-EGFP-IRES-CreERT2 (<italic>Lgr5</italic>-EGFP) mice to obtain 8-week-old <italic>H11<sup>i.enh</sup>;Lgr5-EGFP</italic> mice. Small intestinal crypts were respectively harvested from <italic>Lgr5-EGFP</italic> and <italic>H11<sup>i.enh</sup>;Lgr5-EGFP</italic> mice followed by enrichment of both eGFP+ and eGFP- cells (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref>). Quantitative reverse transcription PCR (RT-qPCR) analyses indicated that <italic>LacZ</italic> transcripts could be detected in both eGFP+ and eGFP- crypt cells in <italic>H11<sup>i.enh</sup>;Lgr5-EGFP</italic> mice (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref>). Next, sections of <italic>H11<sup>i.enh</sup></italic> crypts were subjected with β-gal staining followed by immunohistochemistry of OLFM4 (a CBC marker) or lysozyme (a PC marker). Data showed X-gal signals are in close proximity with both OLFM4 and lysozyme (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), suggesting that the activity of ieCtnnb1 is present in both CBCs and PCs.</p><p>We further examined the ieCtnnb1 activity in GI tracts of postnatal day 7 (P7) pups, when GI epithelia are rapidly expanding. The ieCtnnb1-<italic>LacZ</italic> signals could be visualized in epithelia of P7 small and large intestines, aligning well with the distribution of canonical Wnt signaling illustrated by the BAT-Gal mice (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2G and H</xref>). Together, ieCtnnb1 drives transcription in embryonic intestinal epithelia, the base of small intestinal crypts, and large intestinal epithelia of adult mice.</p></sec><sec id="s2-2"><title>ieCtnnb1 knockout decreased the expression of <italic>Ctnnb1</italic> in intestinal epithelia</title><p>We next examined whether ieCtnnb1 controls the transcription of <italic>Ctnnb1</italic> in intestinal epithelia. For this purpose, we employed CRISPR/Cas9-mediated gene editing to delete the genomic region containing ieCtnnb1 (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2I</xref>). Homozygous ieCtnnb1 knockout (<italic>Ctnnb1<sup>Δi.enh</sup></italic>) mice were born in Mendelian ratios and thrived through adulthood. Interestingly, the body weight of 8-week-old male <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice was slightly but significantly lighter than that of wild-type controls (<xref ref-type="fig" rid="fig1">Figure 1D and F</xref>), but the length of small and large intestines of <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice was comparable to that of control mice (<xref ref-type="fig" rid="fig1">Figure 1E, G, and H</xref>). We then collected crypts from small and large intestine, finding that the expression levels of <italic>Ctnnb1</italic> were decreased by 26.5% and 22.3% respectively in <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts (<xref ref-type="fig" rid="fig1">Figure 1I and J</xref>). In contrast, the expression level of <italic>Ctnnb1</italic> in the <italic>Ctnnb1<sup>Δi.enh</sup></italic> liver remained unaltered (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2J</xref>). In addition, the expression of genes located in the same TAD as <italic>Ctnnb1</italic> and ieCtnnb1, including <italic>Ulk4</italic>, <italic>Rpl14,</italic> and <italic>Entpd3</italic>, was not changed in <italic>Ctnnb1<sup>Δi.enh</sup></italic> small intestinal crypts (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2K</xref>). These data suggest that ieCtnnb1 plays a specific role in regulating the transcription of <italic>Ctnnb1</italic> in intestinal epithelia.</p><p>In epithelial tissues, most β-catenin is localized at cell adhesion sites to maintain barrier integrity, while a smaller fraction translocates into the nucleus to activate transcription upon Wnt ligand binding. We therefore carried out nuclear/cytosol fractionation assays, which revealed a substantial decrease in the levels of both nuclear (49.5%) and cytosolic (29.8%) β-catenin in small intestinal crypts of <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice (<xref ref-type="fig" rid="fig1">Figure 1K and L</xref>). RNA-seq transcriptome and RT-qPCR analyses revealed a significant reduction in the expressions of Wnt target genes in <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts. Additionally, the gene set enrichment analysis (GSEA) showed that the expression levels of many components of the Wnt signaling pathway were also downregulated (<xref ref-type="fig" rid="fig1">Figure 1M and N</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Together, the loss of ieCtnnb1 compromised the Wnt signaling in intestinal epithelia by reducing <italic>Ctnnb1</italic> transcription.</p></sec><sec id="s2-3"><title>Loss of ieCtnnb1 altered cellular composition and expression profiles of small intestinal crypts</title><p>The canonical Wnt/β-catenin signaling is essential for the construction and homeostasis of intestinal epithelia (<xref ref-type="bibr" rid="bib42">Mah et al., 2016</xref>). Because ieCtnnb1 maintains the expression level of <italic>Ctnnb1</italic> of intestinal crypts, we investigated how the deletion of ieCtnnb1 affects cellular components and functions of intestinal crypts. We performed single-cell sequencing on EpCAM+ epithelial cells from small intestinal crypts of 10-week-old <italic>Ctnnb1<sup>Δi.enh</sup></italic> and control (<italic>H11<sup>i.enh</sup></italic>) mice (n=2 female mice for each genotype) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib3">Ayyaz et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Huang et al., 2022</xref>). Uniform Manifold Approximation and Projection (UMAP) was employed for dimensionality reduction to cluster cells, then well-established marker genes for intestinal epithelial cells were mapped onto the UMAP representation to designate cell types (<xref ref-type="bibr" rid="bib24">Haber et al., 2017</xref>; <xref ref-type="bibr" rid="bib22">Gu et al., 2022</xref>; <xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B–D</xref>). Of note, a small population of crypt cells remains undefined, as we did not exclude non-epithelial cells such as immune cells, erythrocytes, or endothelial cells during the enrichment of EpCAM+ epithelial cells. Additionally, our focus was exclusively on epithelial cell types, and we did not consider other cell types when defining cell populations (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). First, in accordance with bulk RNA-seq and RT-qPCR results, the expression levels of <italic>Ctnnb1</italic> were downregulated in almost all <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypt cells, and the expression of <italic>Axin2</italic> was decreased in CBCs and TACs (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>). Second, the proportion of PCs was decreased by 49.2% in <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts, which was confirmed by the immunohistochemical (IHC) staining of <italic>Defensin 5α</italic>, a PC marker (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>). The ieCtnnb1-driving <italic>LacZ</italic> could be detected in the PC cluster (n=four 10-week-old mice) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). Accordingly, the expression levels of examined PC markers – <italic>Lyz1</italic>, <italic>Pla2g2a</italic>, <italic>Wnt3,</italic> and <italic>Math1</italic> – were all significantly compromised in <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). The number of GCs was slightly (not statistically significant) reduced upon loss of ieCtnnb1 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>). Third, the proliferative capability of CSCs and TACs were mildly reduced in <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts, as the proportion of G2/M cells and the expression of <italic>Mki67</italic> were decreased in the two cell types (<xref ref-type="fig" rid="fig2">Figure 2H–J</xref>). Consistently, the numbers of Ki67-positive cells and EdU-labeled cells (4 hr pulse) were decreased by 16.1% and 21.9%, respectively, in <italic>Ctnnb1<sup>Δi.enh</sup></italic> small intestinal epithelia (<xref ref-type="fig" rid="fig2">Figure 2K and L</xref>). Fourth, in secretory cells (PCs, GCs, and EECs), as well as enterocytes/absorptive cells (mature enterocytes [mECs] and immature enterocytes [imECs], and stem cells of <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts), the expression of genes related to secretory functions including <italic>Lyz1</italic>, <italic>Ang4</italic>, <italic>Muc2</italic>, and <italic>Mmp7</italic> was decreased. In contrast, the expression of markers for absorptive cells such as <italic>Fabp6</italic>, <italic>Apoa1</italic>, <italic>Fabp2</italic>, and <italic>Reg3b</italic> was elevated (<xref ref-type="fig" rid="fig2">Figure 2M and N</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>). Accordingly, gene ontology (GO) analyses showed in stem cells and secretory cells of <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts, upregulated genes were enriched with terms associated with absorptive functions including ribosome biogenesis and oxidative phosphorylation, whereas downregulated genes in stem cells and secretory cells were respectively enriched with terms related to cell division and secretory functions (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H and I</xref>). In contrast, in mECs, downregulated genes were enriched with terms associated with absorptive functions (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1J</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>ieCtnnb1 knockout altered cellular composition and expression profiles of small intestinal crypts.</title><p>(<bold>A</bold>) Schematic illustration of single-cell sequencing. Crypts were extracted from small intestines followed by fluorescence activated cell sorting (FACS) to enrich EpCAM+ DAPI- epithelial cells. Cells of two 10-week-old female mice for each genotype were pooled together to perform single-cell transcriptome analyses. (<bold>B</bold>) Uniform Manifold Approximation and Projection (UMAP) were used to visualize the clustering of 11,824 single cells from <italic>H11<sup>i.enh</sup></italic> mice and 8,094 single cells from <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice. Cell types were assigned according to expressions of marker genes. CBC, crypt base columnar cell; TAC, transit-amplifying cell; EEC, enteroendocrine cell; imEC, immature enterocytes; mEC, mature enterocytes; GC, goblet cell; PC, Paneth cell; TC, tuft cell. (<bold>C</bold>) Expression and distribution of <italic>Ctnnb1</italic> in small intestinal crypt cells of <italic>H11<sup>i.enh</sup></italic> and <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice. (<bold>D</bold>) Violin plots showing the expression of <italic>Ctnnb1</italic> in CBC, TAC, PC, GC, imEC, mEC; and the expression of <italic>Axin2</italic> in CBC and TAC, of <italic>H11<sup>i.enh</sup></italic> and <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice. (<bold>E</bold>) Comparison of the proportion of indicated small intestinal crypt cell types in <italic>H11<sup>i.enh</sup></italic> and <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice. (<bold>F</bold>) Immunohistochemistry (left and middle) and quantification (right) of PCs in small intestines of <italic>H11<sup>i.enh</sup></italic> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=6) mice. (<bold>G</bold>) Quantitative reverse transcription PCR (RT-qPCR) showing relative mRNA levels of PC marker genes (<italic>Lyz1, Pla2g2a, Wnt3, Math1</italic>) in small intestinal crypts of <italic>H11<sup>i.enh</sup></italic> (n=3) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=3) mice. (<bold>H</bold>) Distribution of G2M cells in <italic>H11<sup>i.enh</sup></italic> and <italic>Ctnnb1<sup>Δi.enh</sup></italic> small intestinal crypts, based on the expression of cell cycle marker gene <italic>Mki67</italic>. (<bold>I</bold>) Comparison of the proportion of G2M cells in CBC and TAC of <italic>H11<sup>i.enh</sup></italic> and <italic>Ctnnb1<sup>Δi.enh</sup></italic> small intestinal crypts. (<bold>J</bold>) Violin plots showing the expression of <italic>Mki67</italic> in CBC and TAC of <italic>H11<sup>i.enh</sup></italic> and <italic>Ctnnb1<sup>Δi.enh</sup></italic> small intestinal crypts. (<bold>K</bold>) Immunohistochemistry (left and middle) and quantification (right) of Ki67+ cells in small intestines of <italic>H11<sup>i.enh</sup></italic> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=6) mice. (<bold>L</bold>) Immunofluorescence (left and middle) and quantification (right) of EdU+ cells (red) in small intestines of <italic>H11<sup>i.enh</sup></italic> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=6) mice after 4 hr EdU injection. Nuclei were labeled with DAPI (blue). (<bold>M–N</bold>) Violin plots showing expressions of marker genes for secretory cells (<italic>Lyz1, Ang4, Muc2, Mmp7</italic>) and absorptive cells (<italic>Fabp6, Apoa1, Fabp2, Reg3b</italic>) in secretory(M) and absorptive lineages (<bold>N</bold>) of <italic>H11<sup>i.enh</sup></italic> and <italic>Ctnnb1<sup>Δi.enh</sup></italic> small intestinal crypts. Scale bars, 50 μm (F, K, and L). Quantification data are shown as means ± SEM, statistical significance was determined using an unpaired two-tailed Student’s <italic>t</italic>-test (<bold>D, F, J, K, L, M, and N</bold>). Quantification data are shown as means ± SD, statistical significance was determined using Multiple <italic>t</italic>-tests – one per row (<bold>G</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig2">Figure 2F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig2">Figure 2G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig2-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata4"><label>Figure 2—source data 4.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig2">Figure 2I</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig2-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata5"><label>Figure 2—source data 5.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig2">Figure 2K</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig2-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata6"><label>Figure 2—source data 6.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig2">Figure 2L</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig2-data6-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Single-cell survey of small intestinal crypt cells upon ieCtnnb1 knockout.</title><p>(<bold>A</bold>) Flow cytometry assays for isolating EpCAM+ DAPI- epithelial cells from <italic>H11<sup>i.enh</sup></italic> (n=2) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=2) small intestinal crypts. (<bold>B</bold>) Results of cell filtration using DoubletFinder. 1,294 doublets of 11,824 cells from <italic>H11<sup>i.enh</sup></italic> crypts and 567 doublets of 8,094 cells from <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts were identified (blue dots: singlets, red dots: doublets). (<bold>C</bold>) Results of cell filtration using Seurat. Cells with more than 30% of reads derived from mitochondrial genes are considered dead and removed from the analysis. (<bold>D</bold>) Cell-type-specific signatures. Heatmap showing relative expression levels (row-wise Z scores) of genes (rows) in cell-type-specific signatures. (<bold>E</bold>) Uniform Manifold Approximation and Projection (UMAP) visualizing LacZ+ single cells (black dots) of <italic>H11<sup>i.enh</sup></italic> small intestinal crypts (n=4 mice). (<bold>F</bold>) Alcian Blue PAS staining and quantification of goblet cells in the small intestine of <italic>H11<sup>i.enh</sup></italic> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup></italic> (n=6) mice. (<bold>G</bold>) Violin plots showing expressions of marker genes for secretory cells (<italic>Lyz1, Ang4, Muc2, Mmp7</italic>) and absorptive cells (<italic>Fabp6, Apoa1, Fabp2, Reg3b</italic>) in <italic>H11<sup>i.enh</sup></italic> and <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypt base columnar (CBCs) and transit-amplifying cells (TACs). (<bold>H–J</bold>) Gene ontology (GO) analysis of differential genes in stem cell lineage (<bold>H</bold>), secretory lineage (<bold>I</bold>), and mature enterocytes (<bold>J</bold>) of <italic>H11<sup>i.enh</sup></italic> and <italic>Ctnnb1<sup>Δi.enh</sup></italic> crypts. Scale bars, 50 μm (<bold>E</bold>), 10 μm (magnified views in E). Quantification data are shown as means ± SEM, statistical significance was determined using an unpaired two-tailed Student’s <italic>t</italic>-test (<bold>F and G</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig2-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig2-figsupp1-v1.tif"/></fig></fig-group><p>In summary, the loss of ieCtnnb1 results in a reduction in the number of PCs, compromises stem cell proliferation, and disrupts the expression of genes related to secretory and absorptive functions. These effects could be attributed to a combination of reduced Wnt/β-catenin signaling and dysregulated crosstalk among crypt cells.</p></sec><sec id="s2-4"><title>ieCtnnb1 deletion inhibits tumorigenesis of intestinal cancers by suppressing Wnt/β-catenin signaling</title><p>Tumorigenesis of most CRC is associated with aberrant activation of the Wnt/β-catenin signaling (<xref ref-type="bibr" rid="bib79">Zhu and Li, 2023</xref>). To investigate whether knockout of ieCtnnb1 could suppress the carcinogenesis of Wnt-driven intestinal tumors, we crossbred <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice with <italic>Apc<sup>Min/+</sup></italic> mice. In <italic>Apc<sup>Min/+</sup></italic> mice, a nonsense mutation of the <italic>Apc</italic> gene results in the translation of truncated and dysfunctional APC protein, leading to failed degradation and nuclear translocation of β-catenin. <italic>Apc<sup>Min/+</sup></italic> mice spontaneously develop intestinal tumors due to enhanced canonical Wnt/β-catenin signaling in the intestinal epithelia, particularly in stem cells (<xref ref-type="bibr" rid="bib62">Su et al., 1992</xref>). The survival period of <italic>Ctnnb1<sup>Δi.enh</sup>;Apc<sup>Min/+</sup></italic> mice (median survival – 255 days) was significantly longer than the <italic>Apc<sup>Min/+</sup></italic> mice (median survival – 165 days), with the former having a heavier body weight (<xref ref-type="fig" rid="fig3">Figure 3A and C</xref>). Strikingly, the <italic>Ctnnb1<sup>Δi.enh</sup>;Apc<sup>Min/+</sup></italic> mice barely grow CRCs and have much fewer intestinal tumors compared to <italic>Apc<sup>Min/+</sup></italic> mice, with significantly smaller tumor area (<xref ref-type="fig" rid="fig3">Figure 3B and D–F</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–C</xref>). IHC analyses showed that tumors in <italic>Ctnnb1<sup>Δi.enh</sup>;Apc<sup>Min/+</sup></italic> large and small intestines had much fewer Ki67+ proliferating cells, expressed significant less β-catenin, but contained more Muc2-expressing GCs, suggesting <italic>Ctnnb1<sup>Δi.enh</sup>;Apc<sup>Min/+</sup></italic> tumors behave like normal epithelia (<xref ref-type="fig" rid="fig3">Figure 3G–L</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D–I</xref>). Consistently, RNA-seq transcriptome experiments showed that <italic>Ctnnb1<sup>Δi.enh</sup>;Apc<sup>Min/+</sup></italic> CRCs significantly downregulated genes associated with the Wnt signaling pathway, pluripotency of stem cells, and gastric cancer, whereas increased expression of genes related to normal epithelial functions including oxidative phosphorylation, adhesion, protein digestion and absorption, and mucin biosynthesis (<xref ref-type="fig" rid="fig3">Figure 3M–O</xref>). Thus, ablation of ieCtnnb1 deters tumorigenesis of intestinal cancers by suppressing the Wnt signaling.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Knocking out ieCtnnb1 inhibits tumorigenesis of colorectal cancer.</title><p>(<bold>A</bold>) Survival of <italic>Apc</italic><sup>Min/+</sup> (n=15) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=17) mice. (<bold>B</bold>) Colon images of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=9) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=9) mice. (<bold>C</bold>) Weight statistics of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=20) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=20) mice. (<bold>D</bold>) The statistical analysis of tumor counts in colons of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=9) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=9) mice. (<bold>E</bold>) Representative H&amp;E staining images of colon sections of 5-month-old <italic>Apc</italic><sup>Min/+</sup> and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> mice. (<bold>F</bold>) The statistical analysis of colon tumor area in 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=6) mice. (<bold>G–H</bold>) Immunohistochemistry (<bold>G</bold>) and quantification (<bold>H</bold>) of Ki67+ cells in colon tumors of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=6) mice. (<bold>I–J</bold>) Immunohistochemistry (<bold>I</bold>) and signal intensity statistics (J, red dashed boxes of I) of β-catenin in colon tumors of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=6) mice. (<bold>K–L</bold>) Immunohistochemistry (<bold>K</bold>) and quantification (<bold>L</bold>) of MUC2+ cells in colon tumors of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=6) mice. (<bold>M</bold>) The heatmap showing relative expressions of Wnt signaling pathway genes of colon tumors from 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=3) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=3) mice. (<bold>N–O</bold>) KEGG analyses of downregulated (<bold>N</bold>) and upregulated (<bold>O</bold>) genes in colon tumors of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=3) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=3) mice. Scale bars, 1 cm (<bold>B</bold>), 4 mm (<bold>E, G, I, and K</bold>), 200 μm (magnified views in G and K), 100 μm (magnified views in I). Quantification data are shown as means ± SEM, statistical significance was determined using an unpaired two-tailed Student’s <italic>t</italic>-test (<bold>C, D, F, H, J, and L</bold>) or log-rank analysis (<bold>A</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3">Figure 3A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3">Figure 3C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3">Figure 3D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3">Figure 3F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata5"><label>Figure 3—source data 5.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3">Figure 3H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata6"><label>Figure 3—source data 6.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3">Figure 3L</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-data6-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Knocking out ieCtnnb1 inhibits tumorigenesis of small intestine.</title><p>(<bold>A</bold>) Statistical analyses of tumor counts in small intestines of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=20) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=20) mice. (<bold>B</bold>) Representative H&amp;E staining images of small intestine sections of 5-month-old <italic>Apc</italic><sup>Min/+</sup> and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> mice. (<bold>C</bold>) The statistical analysis of small intestinal tumor area in 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=6) mice. (<bold>D–E</bold>) Immunohistochemistry (<bold>D</bold>) and quantification (<bold>E</bold>) of Ki67+ cells in small intestinal tumors of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=6) mice. (<bold>F–G</bold>) Immunohistochemistry (<bold>F</bold>) and signal intensity statistics (G, red dashed boxes of F) of β-catenin in small intestinal tumors of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=6) mice. (<bold>H–I</bold>) Immunohistochemistry (<bold>H</bold>) and quantification (<bold>I</bold>) of MUC2+ cells in small intestinal tumors of 5-month-old <italic>Apc</italic><sup>Min/+</sup> (n=6) and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n=6) mice. Scale bars, 4 mm (<bold>B, D, F, and H</bold>), 200 μm (magnified views in D and H), 100 μm (magnified views in F). Quantification data are shown as means ± SEM, statistical significance was determined using an unpaired two-tailed Student’s <italic>t</italic>-test (<bold>C, E, G, and I</bold>) or Multiple <italic>t</italic>-tests – one per row (<bold>A</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata3"><label>Figure 3—figure supplement 1—source data 3.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata4"><label>Figure 3—figure supplement 1—source data 4.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1I</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig3-figsupp1-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Human ieCTNNB1 drives the expression of reporter gene in the GI tract</title><p>We next investigated whether the human genome also harbors an intestinal enhancer for <italic>CTNNB1</italic>. A region with open chromatin (DNase I hypersensitivity) and enrichment of H3K27ac/H3K4me1 was identified at 38,489 bp upstream of human <italic>CTNNB1</italic> in adult small intestine and colon tissues (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Moreover, the H3K27ac enrichment is also present in esophagus but not in non-GI tissues (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Similar to ieCtnnb1, the 3-kb-long human genomic region, named as ieCTNNB1, resides in the same TAD as the promoter of <italic>CTNNB1</italic> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). We generated ieCTNNB1 reporter mice (<italic>H11<sup>hi.enh</sup></italic>) and observed that ieCTNNB1 could drive <italic>LacZ</italic> expression in the bottom of small intestinal crypts and the entire epithelia of large intestine, also exhibiting a proximal-low to distal-high pattern (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Notably, the LacZ signal driven by human ieCTNNB1 was less intense than that driven by mouse ieCtnnb1, potentially attributed to species-specific TF-enhancer interactions.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>ieCTNNB1 is the intestinal enhancer of human <italic>CTNNB1</italic>.</title><p>(<bold>A</bold>) Schematic representation of human <italic>CTNNB1</italic> gene and the location of ieCTNNB1 (3,000 bp, pink shading), which is marked by H3K27ac and H3K4me1 peaks, and DNaseI hypersensitivity in human small intestine (30-year-old female) and colon (34-year-old male). Data were obtained from ENCODE. (<bold>B</bold>) Top: a schematic illustration showing that the knock-in construct containing the <italic>Shh</italic> promoter, ieCTNNB1 sequences (3,000 bp), and the LacZ reporter gene. Bottom: X-Gal staining (blue) of the gastrointestinal tract, and sections of the proximal small intestine, distal small intestine, and large intestine in 8-week-old <italic>H11<sup>hi.enh</sup></italic> mice. (<bold>C</bold>) Left: ieCTNNB1 is marked by enrichment of H3K27ac in human small intestine (30-year-old female) and colon (34-year-old male). Data were obtained from ENCODE. Locations of single-guide RNA (sgRNA) target sites were indicated. Five subregions of ieCTNNB1 were shown. Right: luciferase reporter assay in HCT116 cells transfected with indicated plasmids for 48 hr. (<bold>D</bold>) Quantitative reverse transcription PCR (RT-qPCR) showing relative mRNA levels of <italic>CTNNB1</italic> in HCT-15 cells transfected with indicated CRISPR activation or CRISPR interference vectors for 48 hr. Scale bars, 1 cm (whole mount in B), 100 μm (sections in B), 10 μm (magnified views in B). Quantification data are shown as means ± SEM, statistical significance was determined using one-way ANOVA (<bold>C</bold>) and an unpaired two-tailed Student’s <italic>t</italic>-test (<bold>D</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig4">Figure 4C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig4-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig4">Figure 4D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig4-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>ieCTNNB1 is the intestinal enhancer of human <italic>CTNNB1</italic>.</title><p>(<bold>A</bold>) Schematic representation of the upstream region of human <italic>CTNNB1</italic> gene and the location of ieCTNNB1 (gray shading). Enrichment of H3K27ac chromatin immunoprecipitation sequencing (ChIP-seq) signals in indicated human tissues was shown. Data were obtained from ENCODE. (<bold>B</bold>) Hi-C data of SW480 cells. Boundaries of the topologically associating domains (TADs) and locations of <italic>CTNNB1</italic> promoter and ieCTNNB1 (green bar) were marked. (<bold>C</bold>) Luciferase reporter assays of HeLa cells transfected with indicated plasmids for 48 hr. Quantification data are shown as means ± SEM, statistical significance was determined using one-way ANOVA (<bold>C</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig4-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig4-figsupp1-v1.tif"/></fig></fig-group><p>The H3K27ac-enriched region of ieCTNNB1 was divided into five equal parts for the luciferase reporter assay. Experiments demonstrated that each of the five ieCTNNB1 subregions individually increased luciferase activity in both HCT116 and HeLa cells (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). We then conducted CRISPR-mediated activation and interference in HCT-15 CRC cells using three guide RNAs (gRNAs) targeting ieCTNNB1, which respectively enhanced and inhibited transcription of <italic>CTNNB1</italic> (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Together, ieCTNNB1 is the intestinal enhancer of <italic>CTNNB1</italic> for human GI epithelia.</p></sec><sec id="s2-6"><title>ieCTNNB1 is activated in CRC and its activity positively correlates with the expression of <italic>CTNNB1</italic></title><p>CRC, one of the most prevalent cancers in human, is often associated with aberrant activation of the Wnt signaling (<xref ref-type="bibr" rid="bib35">Li et al., 2021a</xref>). We then studied whether the occurrence of CRC is associated with enhancer activation of ieCTNNB1. We previously conducted paired analyses of chromatin immunoprecipitation sequencing (ChIP-seq) for H3K27ac and H3K4me3, alongside RNA-seq on 68 CRC samples and their adjacent normal (native) tissue (<xref ref-type="bibr" rid="bib35">Li et al., 2021a</xref>). In the current study, we performed analyses for the enrichment of H3K27ac and H3K4me3 at ieCTNNB1 and <italic>CTNNB1</italic> promoter regions, as well as the expression levels of <italic>CTNNB1</italic>, followed by combined analyses (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). As anticipated, the expression levels of <italic>CTNNB1</italic> in CRC samples were significantly higher than those in neighboring native tissues (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Essentially, the enrichment of H3K27ac at ieCTNNB1 in CRC tissues were significantly higher than that in native tissues (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). In contrast, the enrichment of H3K4me3 at <italic>CTNNB1</italic>’s promoter was comparable between cancer and native tissues (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Moreover, the enrichment of H3K27ac at ieCTNNB1 positively correlated with the expression of <italic>CTNNB1</italic>, but the enrichment of H3K4me3 at <italic>CTNNB1</italic>’s promoter was not associated with <italic>CTNNB1</italic>’s expression (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Therefore, it’s the activity of enhancer but not the promoter that reflects the occurrence of CRC and expression levels of <italic>CTNNB1</italic>.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>ieCTNNB1 is activated in colorectal cancer and its activity positively correlates with the expression of <italic>CTNNB1</italic>.</title><p>(<bold>A</bold>) Schematic representation of ieCTNNB1 (pink shading) and <italic>CTNNB1</italic> promoter (yellow shading), which is respectively marked by H3K27ac and H3K4me3 peaks, and mRNA signals in native and tumor tissues of a patient with colorectal cancer. The location of risk mutation site was indicated. (<bold>B</bold>) Comparison of <italic>CTNNB1</italic> expression levels in native and tumor tissues of colorectal cancer patients (n=68). (<bold>C</bold>) Left: comparison of H3K27ac signals at ieCTNNB1 in native and tumor tissues of colorectal cancer patients (n=64). Right: comparison of H3K4me3 signals at <italic>CTNNB1</italic> promoter in native and tumor tissues of colorectal cancer patients (n=42). (<bold>D</bold>) Left: correlation between H3K27ac signals at ieCTNNB1 and <italic>CTNNB1</italic> expression in native and tumor tissues of colorectal cancer patients (n=55). Right: correlation between H3K4me3 signals at <italic>CTNNB1</italic> promoter and <italic>CTNNB1</italic> expression in native and tumor tissues of colorectal cancer patients (n=38). (<bold>E</bold>) Left: comparison of <italic>CTNNB1</italic> expression in esophagus between subjects with common sequence (C/C, n=428) and variant sequence (C/T, n=37). Right: comparison of <italic>CTNNB1</italic> expression in transverse colon between subjects with common sequence (C/C, n=343) and variant sequence (C/T, n=25). (<bold>F</bold>) Luciferase reporter assay in HCT116 and HeLa cells transfected with indicated plasmids for 48 hr. Quantification data are shown as means ± SEM, statistical significance was determined using a paired (<bold>B, C, and D</bold>) or unpaired (<bold>E</bold>) two-tailed Student’s <italic>t</italic>-test and two-way ANOVA (<bold>F</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant. R: Pearson correlation.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig5-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>ieCTNNB1 is activated in colorectal cancer.</title><p>(<bold>A</bold>) H3K27ac chromatin immunoprecipitation sequencing (ChIP-seq) signals at ieCTNNB1 (blue shading) in paired tumor (top) and native (bottom) tissues of patients with colorectal cancer (n=64).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig5-figsupp1-v1.tif"/></fig></fig-group><p>By examining Genotype Tissue Expression (GTEx) eQTL data browser, an SNP, rs15981379 (C&gt;T) within ieCTNNB1 was discovered (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Importantly, the C&gt;T variation is inversely correlated with the expression levels of <italic>CTNNB1</italic> in the esophagus and transverse colon (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Luciferase reporter assays in HCT116 and HeLa cells revealed that the C&gt;T variation indeed compromised luciferase activity driven by the ieCTNNB1 region 1 (<xref ref-type="fig" rid="fig5">Figure 5F</xref>).</p></sec><sec id="s2-7"><title>HNF4α and p-S133-CREB1 bind to ieCTNNB1 and maintains the expression of <italic>CTNNB1</italic></title><p>Characterizing associated trans-factors of ieCtnnb1 and ieCTNNB1 is essential for revealing related transcriptional mechanisms and holds clinical relevance. By examining Cistrome Data Browser for ChIP-seq data, eight trans-factors were found to associate with ieCTNNB1 in human CRC cells or ieCtnnb1 in mouse GI tissues (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). Moreover, they are relatively highly expressed and/or have positive correlation with <italic>CTNNB1</italic>’s expression in colon cancer samples. We then transduced shRNAs-expressing plasmids into HCT-15 cells to individually downregulate their expressions, revealing that decreasing the expression of <italic>CREB1</italic> (cAMP responsive element binding protein 1) or <italic>HNF4A</italic> (hepatocyte nuclear factor 4 alpha) could compromise <italic>CTNNB1</italic>’s transcription (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). Of note, HNF4α plays crucial roles in the normal development of the colon and the maintenance of epithelial barrier (<xref ref-type="bibr" rid="bib20">Garrison et al., 2006</xref>; <xref ref-type="bibr" rid="bib10">Cattin et al., 2009</xref>). The phosphorylation of CREB1 at serine 133 (p-S133-CREB1) is essential for its role in activation of gene transcription (<xref ref-type="bibr" rid="bib9">Carlezon et al., 2005</xref>). ChIP-qPCR experiments showed that enrichment of p-S133-CREB1 was more prominent than CREB1 at ieCtnnb1 in small intestinal crypts and at ieCTNNB1 in HCT-15 cells (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). Notably, HNF4α and p-S133-CREB1 bind to multiple subregions of ieCTNNB1 and ieCtnnb1, as well as the promoters of <italic>CTNNB1</italic> and <italic>Ctnnb1</italic> (<italic>pCTNNB1</italic> and <italic>pCtnnb1</italic>) in HCT-15 cells and small intestinal crypts (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C and D</xref>). By analyzing the GEIPA-COAD (colon adenocarcinoma) and READ (rectum adenocarcinoma) database, expression levels of <italic>CREB1</italic> and <italic>HNF4A</italic> were found to be significantly higher in colon and rectum cancer samples than those of normal tissues (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Furthermore, expression levels of <italic>CREB1</italic> and <italic>HNF4A</italic> positively correlated with that of <italic>CTNNB1</italic> (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). HNF4α and p-S133-CREB1 were significantly enriched at the promoter of <italic>Ctnnb1</italic> in <italic>Apc</italic> mutation induced colon cancer tissues (<xref ref-type="fig" rid="fig6">Figure 6G and H</xref>). Intriguingly, knockout of ieCtnnb1 greatly diminished the association of HNF4α and p-S133-CREB1 with <italic>Ctnnb1</italic>’s promoter (<xref ref-type="fig" rid="fig6">Figure 6G and H</xref>). In summary, HNF4α and p-S133-CREB1 were identified as essential trans-factors that bind to ieCTNNB1 and maintain <italic>CTNNB1</italic>’s expression.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>HNF4α and p-S133-CREB1 associate with ieCTNNB1 to regulate <italic>CTNNB1</italic>’s transcription.</title><p>(<bold>A</bold>) Chromatin immunoprecipitation sequencing (ChIP-seq) tracks of indicated trans-acting factors enriched at ieCTNNB1 (pink shading) and <italic>CTNNB1</italic> promoter (gray shading) in indicated colorectal cancer cell lines. Shaded regions were enlarged in C (pink) and D (gray) respectively. (<bold>B</bold>) Quantitative reverse transcription PCR (RT-qPCR) showing relative mRNA levels of <italic>CTNNB1</italic> in HCT-15 cells transfected with indicated shRNA-expressing plasmids for 48 hr. The expression level of <italic>CTNNB1</italic> in cells transfected with scramble (scr) shRNA was set to ‘1’. (<bold>C–D</bold>) Top: schematic diagram showing the enrichment of p-S133-CREB1 at ieCTNNB1 (<bold>C</bold>) and <italic>CTNNB1</italic>’s promoter (<bold>D</bold>). Locations of HNF4α and CREB1 binding motif sites were indicated. Middle and bottom: ChIP-qPCR showing enrichment of HNF4α (middle), CREB1 and p-S133-CREB1 (bottom) at ieCTNNB1 (<bold>C</bold>), and <italic>CTNNB1</italic>’s promoter (<bold>D</bold>) in HCT-15 cells. Locations of ChIP regions were indicated. (<bold>E</bold>) Comparison of expression levels of <italic>CREB1</italic> and <italic>HNF4A</italic> between native and tumor tissues in colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) tumors. (<bold>F</bold>) Correlations between the expression level of <italic>CTNNB1</italic> and those of <italic>CREB1</italic> or <italic>HNF4A</italic> in COAD tumors. (<bold>G–H</bold>) ChIP-qPCR showing enrichment of HNF4α (<bold>G</bold>) and p-S133-CREB1 (<bold>H</bold>) at <italic>Ctnnb1</italic> promoter in native colon tissues of WT (n= 3) mice, tumor tissues of <italic>Apc</italic><sup>Min/+</sup> (n= 3) mice, and <italic>Ctnnb1<sup>Δi.enh</sup>;Apc</italic><sup>Min/+</sup> (n= 3) mice. Quantification data are shown as means ± SEM, statistical significance was determined using one-way ANOVA (<bold>B</bold>), unpaired two-tailed Student’s <italic>t</italic>-test (<bold>E and F</bold>), and Multiple <italic>t</italic>-tests – one per row (<bold>C, D, G, and H</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant. R: Pearson correlation.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig6-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6">Figure 6C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig6-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6">Figure 6D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig6-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata4"><label>Figure 6—source data 4.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6">Figure 6G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig6-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata5"><label>Figure 6—source data 5.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6">Figure 6H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig6-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>HNF4α and p-S133-CREB1 associate with ieCtnnb1 to regulate <italic>Ctnnb1</italic>’s transcription.</title><p>(<bold>A</bold>) Chromatin immunoprecipitation sequencing (ChIP-seq) tracks of indicated trans-acting factors enriched at ieCtnnb1 (pink shading) and <italic>Ctnnb1</italic> promoter (gray shading) in mouse intestinal tissues and organoids. Shaded regions were enlarged in C (pink) and D (gray) respectively. (<bold>B</bold>) Relative mRNA levels of indicated genes in HCT-15 cells transfected with indicated shRNA-expressing plasmids for 48 hr. (<bold>C–D</bold>) Top: schematic diagram showing the enrichment of HNF4α at ieCtnnb1 (<bold>C</bold>) and <italic>Ctnnb1</italic>’s promoter (<bold>D</bold>). Locations of the HNF4α and CREB1 binding motif sites were indicated. Middle and bottom: ChIP-qPCR showing enrichment of HNF4α (middle), CREB1 and p-S133-CREB1 (bottom) at ieCtnnb1 (<bold>C</bold>), and <italic>Ctnnb1</italic>’s promoter (<bold>D</bold>) in small intestinal crypts. ChIP regions were indicated. (<bold>E</bold>) The comparison of numbers (left) and proportions (right) of species-specific and shared transcription factor binding sites within ieCtnnb1 and ieCTNNB1. Quantification data are shown as means ± SEM, statistical significance was determined using an unpaired two-tailed Student’s <italic>t</italic>-test (<bold>B</bold>) and Multiple <italic>t</italic>-tests – one per row (<bold>C and D</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. ns, not significant.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig6-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata2"><label>Figure 6—figure supplement 1—source data 2.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig6-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata3"><label>Figure 6—figure supplement 1—source data 3.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig6-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata4"><label>Figure 6—figure supplement 1—source data 4.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98238-fig6-figsupp1-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig6-figsupp1-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The intestinal epithelia replenish themselves rapidly throughout lifetime, which enables regeneration while predisposes to GI cancers (<xref ref-type="bibr" rid="bib15">Clevers, 2013</xref>). The optimal strength and dynamics of canonical Wnt/β-catenin signaling is central to both homeostasis and tumorigenesis of GI tracts (<xref ref-type="bibr" rid="bib53">Pinto et al., 2003</xref>; <xref ref-type="bibr" rid="bib44">Maretto et al., 2003</xref>; <xref ref-type="bibr" rid="bib7">Beumer and Clevers, 2016</xref>). While the stabilization and nuclear translocation of β-catenin is the key step for Wnt signaling activation, the transcriptional control of <italic>Ctnnb1</italic> could be another layer of regulation (<xref ref-type="bibr" rid="bib76">Zhang and Wang, 2020</xref>; <xref ref-type="bibr" rid="bib56">Rim et al., 2022</xref>). Here, we unveiled an enhancer-dependent transcriptional machinery that tunes expressions of <italic>Ctnnb1</italic> in multiple cell types of intestinal crypts, thereby balancing homeostasis and tumorigenesis of intestinal epithelia (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>The working model.</title><p>ieCtnnb1, the intestinal enhancer of <italic>Ctnnb1</italic>, balances epithelial homeostasis and tumorigenesis by transcriptionally controlling Wnt signaling dosage.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-fig7-v1.tif"/></fig><p>Our findings reinforce the notion that the canonical Wnt signaling is required for the establishment of the secretory cell lineage (<xref ref-type="bibr" rid="bib53">Pinto et al., 2003</xref>; <xref ref-type="bibr" rid="bib66">van Es et al., 2005</xref>; <xref ref-type="bibr" rid="bib54">Pinto and Clevers, 2005</xref>). Expression levels of markers for secretory cells were greatly reduced whereas levels of markers for absorptive cells were elevated in all small intestinal crypt cells of <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice. Fate determinations of CBC daughter cells occur upon leaving the stem cell niche, exposed to changing WNT, Notch, and EGF levels. Progenitors losing contact with PC Notch ligands upregulate DLL1 and DLL4, commit to the secretory lineage, and induce Notch activity in neighboring cells, promoting EC differentiation (<xref ref-type="bibr" rid="bib67">van Es et al., 2012</xref>; <xref ref-type="bibr" rid="bib8">Beumer and Clevers, 2021</xref>).</p><p>WNT signaling not only directs PC-fated progenitors toward the crypt bottom but also directly induces their differentiation (<xref ref-type="bibr" rid="bib66">van Es et al., 2005</xref>; <xref ref-type="bibr" rid="bib1">Andreu et al., 2008</xref>; <xref ref-type="bibr" rid="bib8">Beumer and Clevers, 2021</xref>). Single-cell sequencing and reporter gene analyses indicated that the activity of ieCtnnb1 is present in PCs. Knockout of ieCtnnb1 decreases number of PCs by almost 50% but the pool size of CBCs was not significantly altered. A previous study showed that genetic removal of PCs leads to the concomitant loss of Lgr5+ stem cells (<xref ref-type="bibr" rid="bib57">Sato et al., 2011</xref>), while other studies indicated that PCs are not mandatory niche cells for the intestinal epithelia (<xref ref-type="bibr" rid="bib19">Garabedian et al., 1997</xref>; <xref ref-type="bibr" rid="bib18">Durand et al., 2012</xref>; <xref ref-type="bibr" rid="bib29">Kim et al., 2012</xref>). Although Wnt ligands provided by PCs may support Lgr5+ CBCs, essential Wnt ligands are primarily supplied by subepithelial stromal populations (<xref ref-type="bibr" rid="bib17">Degirmenci et al., 2018</xref>; <xref ref-type="bibr" rid="bib60">Shoshkes-Carmel et al., 2018</xref>). The presence of redundancy at the stem cell niche enhances the accuracy in maintaining intestinal homeostasis.</p><p>ieCtnnb1 knockout compromises Wnt signaling dosage, leading to PC loss, dysregulation of genes controlling absorptive and secretory functions of intestinal epithelia, and reduced proliferation of stem cells. These combined effects could account for the lighter body weight observed in adult <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice.</p><p>On the other hand, colon and small intestinal tumors were rarely observed in <italic>Ctnnb1<sup>Δi.enh</sup>;Apc<sup>Min/+</sup></italic> mice. Among the few <italic>Ctnnb1<sup>Δi.enh</sup></italic> tumors analyzed, they exhibited lower <italic>Ctnnb1</italic> expression, reduced proliferation, and behaved more like normal intestinal epithelia. Different truncations or mutations of <italic>APC</italic> lead to specific tumor types throughout the body in a Wnt/β-catenin dosage-dependent manner. For example, although <italic>Apc<sup>1638N</sup>;Ctnnb1<sup>+/-</sup></italic>mice were less prone to GI cancers, <italic>Apc<sup>1638N</sup>;Ctnnb1<sup>+/-</sup></italic> female animals tended to grow breast cancers (<xref ref-type="bibr" rid="bib4">Bakker et al., 2013</xref>). Therefore, the intestinal specificity of ieCtnnb1 makes it an ideal target to lower the strength of Wnt signaling in treating CRC without affecting other tissues (<xref ref-type="bibr" rid="bib25">Hamdan and Johnsen, 2019</xref>; <xref ref-type="bibr" rid="bib50">Orouji et al., 2022</xref>). Importantly, ieCTNNB1 displayed higher enhancer activity in most CRC samples collected in the study. Moreover, the SNP rs15981379 (C&gt;T) within ieCTNNB1 is associated with the expression of CTNNB1 in the GI tract. Future population studies could investigate how the enhancer activity of ieCTNNB1 and this particular SNP are associated with CRC susceptibility and prognosis.</p><p>We noticed that after knocking out ieCtnnb1, the level of β-catenin in the nuclei of small intestinal crypt cells of <italic>Ctnnb1</italic><sup>Δi.enh</sup> mice decreased more significantly compared to that in the cytoplasm (49.5% vs 29.8%). Although the loss of ieCtnnb1 should not directly lead to reduced nuclear translocation of β-catenin, RNA-seq results showed that the loss of ieCtnnb1 causes a reduction in the expression of <italic>Bambi</italic> (BMP and activin membrane-bound inhibitor), a target gene in the canonical Wnt signaling pathway (<xref ref-type="fig" rid="fig1">Figure 1M</xref>). BAMBI promotes the binding of Frizzled to Dishevelled, thereby stabilizing β-catenin and facilitating its nuclear translocation (<xref ref-type="bibr" rid="bib38">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib39">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Mai et al., 2014</xref>; <xref ref-type="bibr" rid="bib75">Zhang et al., 2015</xref>). Thus, it is likely that the decreased level of BAMBI resulting from the loss of ieCtnnb1 further reduced nuclear β-catenin.</p><p>Both mouse ieCtnnb1 and human ieCTNNB1 were able to drive reporter gene expression at the base of small intestinal crypts and throughout the epithelium of the large intestine. Very intriguingly, unlike the highly conserved neCtnnb1 sequence among amniotes, mouse ieCtnnb1 and human ieCTNNB1 do not share significant homology in primary sequence (<xref ref-type="bibr" rid="bib69">Wang et al., 2022</xref>). Nonetheless, both ieCtnnb1 and ieCTNNB1 localize at the intergenic region 30–40 kb upstream of <italic>Ctnnb1</italic>’s promoter. Moreover, both ieCtnnb1 and ieCTNNB1 contain binding motifs for HNF4α and CREB1. HNF4α and p-S133-CREB1 were found to associate with ieCtnnb1 and <italic>Ctnnb1</italic>’s promoter to maintain <italic>Ctnnb1</italic>’s expression. These findings support the notion that conserved TF binding motifs stabilize and preserve enhancer functionality over evolution (<xref ref-type="bibr" rid="bib74">Zabidi and Stark, 2016</xref>; <xref ref-type="bibr" rid="bib70">Wong et al., 2020</xref>). Of note, ieCtnnb1 and ieCTNNB1 contain distinct TF binding motifs, which may respectively exert species-specific roles in regulating the transcription of <italic>Ctnnb1</italic>/<italic>CTNNB1</italic> (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>). Future studies will dissect common and distinct features of motif composition, location, order, and affinity with trans-factors within ieCtnnb1 and ieCTNNB1. This analysis will provide insights how sequence variations of ieCtnnb1 are adapted to intestinal homeostasis of different species. Finally, it would be intriguing to explore how neocortical and intestinal enhancers of <italic>Ctnnb1</italic> controls tissue- and stage-specific transcription, as well as the existence of other potential enhancers of <italic>Ctnnb1</italic>.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Ctnnb1</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">Gene ID: 12387</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom"><italic>CTNNB1</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">Gene ID: 1499</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>ieCtnnb1</italic> knockout</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Received from Beijing Biocytogen, China</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>ieCtnnb1-LacZ</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Received from Shanghai Model Organisms Center Inc, China</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom"><italic>ieCTNNB1-LacZ</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Received from Shanghai Model Organisms Center Inc, China</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">BAT-Gal</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">JAX#005317; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:005317">IMSR_JAX:005317</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Lgr5</italic>-EGFP-IRES-CreERT2</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">JAX#008875; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_NM-KI-200154">IMSR_NM-KI-200154</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Apc<sup>Min/+</sup></italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">JAX#002020; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:3834882">MGI:3834882</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HEK293T</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">CRL-1573; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0045">CVCL_0045</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HCT116</td><td align="left" valign="bottom">China Center for Type Culture Collection</td><td align="left" valign="bottom">GDC0625; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0291">CVCL_0291</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HCT-15</td><td align="left" valign="bottom">China Center for Type Culture Collection</td><td align="left" valign="bottom">GDC0250; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0292">:CVCL_0292</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HeLa</td><td align="left" valign="bottom">China Center for Type Culture Collection</td><td align="left" valign="bottom">GDC0009; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0030">CVCL_0030</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">pHR-SFFV-dCas9-BFP-KRAB</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene">Addgene</ext-link> #46911</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">lenti sgRNA (MS2)_zeo backbone vector</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene">Addgene</ext-link> #61427</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">dCAS9-VP64_GFP</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene">Addgene</ext-link> #61422</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">lenti MS2-P65-HSF1_Hygro</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene">Addgene</ext-link> #61426</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-α-defensin5 (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">CAT#ab180515; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2923196">AB_2923196</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Ki67 (Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">CAT#ab15580; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_443209">AB_443209</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-catenin (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">CAT#8480T; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11127855">AB_11127855</ext-link></td><td align="left" valign="bottom">IHC (1:100)<break/>WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HNF4α<break/>(Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">CAT#ab181604; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2890918">AB_2890918</ext-link></td><td align="left" valign="bottom">ChIP<break/>(1 µg/ml)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CREB1(S133) (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">CAT#ab32096; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_731734">AB_731734</ext-link></td><td align="left" valign="bottom">ChIP<break/>(1 µg/ml)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Muc2<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">CAT#PA5-21329; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11153058">AB_11153058</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-EpCAM FITC (Mouse monoclonal)</td><td align="left" valign="bottom">eBioScience</td><td align="left" valign="bottom">CAT#347197; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_400261">AB_400261</ext-link></td><td align="left" valign="bottom">FACS (1:200)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-promoter-ieCtnnb1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Obtained from Zhou Lab of Wuhan University</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-promoer-ieCTNNB1 Region1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Obtained from Zhou Lab of Wuhan University</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pLKO.1-shRNAs</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Obtained from Zhou Lab of Wuhan University</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">TF-shRNAs</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">ieCtnnb1/<break/>ieCTNNB1 ChIP-qPCR primers</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">ChIP-qPCR primers</td><td align="left" valign="bottom">See <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Genotyping primers</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Dual-Luciferase Reporter Assay System</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">CAT#E1910</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Alcian Blue PAS Stain Kit</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">CAT#ab245876</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">BeyoClick EdU Cell Promotion Kit</td><td align="left" valign="bottom">Beyotime</td><td align="left" valign="bottom">CAT#C0075S</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software</td><td align="left" valign="bottom">Fiji/ImageJ</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://fiji.sc">https://fiji.sc</ext-link></td><td align="left" valign="bottom">v2.0.0; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com">https://www.graphpad.com</ext-link></td><td align="left" valign="bottom">v8.0; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DAPI</td><td align="left" valign="bottom">BD Pharmingen</td><td align="left" valign="bottom">CAT#564907</td><td align="left" valign="bottom">(1 µg/ml)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice and genotyping</title><p>All animal procedures were approved by the Animal Care and Ethical Committee of Medical Research Institute at Wuhan University. C57BL/6 background mice were housed in a temperature- and humidity-controlled environment with 12 hr light/dark cycle and food/water ad libitum. <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice were generated in the Beijing Biocytogen. <italic>H11<sup>i.enh</sup></italic> reporter mice were generated in the Shanghai Model Organisms Center Inc. BAT-Gal mice were provided by Dr. Jun-Lei Chang (Jackson Lab, stock number 005317). <italic>Lgr5</italic>-EGFP-IRES-CreERT2 mice were gifts from Dr. Ye-Guang Chen (Jackson Lab, stock number 008875). <italic>APC<sup>Min/+</sup></italic> mice were gifts from Dr. Bo Zhong (Jackson Lab, stock number 002020). The primer set forward 5′-<named-content content-type="sequence">atcctctgcatggtcaggtc</named-content>-3′/reverse 5′-<named-content content-type="sequence">cgtggcctgattcattcc</named-content>-3′ was used for genotyping of BAT-Gal mice, <italic>H11<sup>i.enh</sup></italic> mice, and <italic>H11<sup>hi.enh</sup></italic> mice with a band size of 315 base pairs (bp). The primer set forward 5′-<named-content content-type="sequence">gtcctgtccgtcactattatcctggc</named-content>-3′/reverse5′-<named-content content-type="sequence">ccactgccctgctaaagcattggt</named-content>-3′/reverse 5′-<named-content content-type="sequence">tgattagttctccgggaagcccagt</named-content>-3′ were used for genotyping of <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice and band sizes for <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice are 482 bp (wild-type allele) and 867 bp (ieCtnnb1 knockout allele). The primer set forward <italic>5′-<named-content content-type="sequence">atctcatggcaaacagacct</named-content>-3′/reverse5′-<named-content content-type="sequence">tcacaaatcatctcgcaga</named-content>-3′</italic> was used for genotyping of <italic>APC<sup>Min/+</sup></italic> mice with a band size of 340 bp. The primer set <italic>forward 5′-<named-content content-type="sequence">ctgctctctgctcccagtct</named-content>-3′/reverse5′-<named-content content-type="sequence">ataccccatcccttttgagc</named-content>-3′/reverse 5′-<named-content content-type="sequence">gaacttcagggtcagcttgc</named-content>-3′</italic> were used for genotyping of <italic>Lgr5</italic>-EGFP-IRES-CreERT2 mice and the band sizes for 386 bp (wild-type allele) and 119 bp (mutant allele).</p></sec><sec id="s4-2"><title>Cell lines</title><p>HEK293T, HCT116, HCT-15, and HeLa cells were purchased from the China Center for Type Culture Collection. The identity of all cell lines has been authenticated through STR profiling and the mycoplasma contamination testing is negative. HEK293T, HeLa, and HCT116 cells were grown in DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS) (Life Technologies) and 1× penicillin/streptomycin (Gibco). HCT-15 cells were maintained in RPMI-1640 (Gibco) containing 10% FBS (Life Technologies) and 1× penicillin/streptomycin (Gibco). For routine culturing, cells were dissociated using 0.25% trypsin (Gibco).</p></sec><sec id="s4-3"><title>Tissue fixation and section</title><p>Intestinal and tumor tissues were dissected and cleaned in pre-cooled phosphate buffered saline (PBS) and immersed in 4% paraformaldehyde (PFA) overnight at 4°C. For sectioning, intestines were embedded in Tissue-Tek O.C.T. Compound (SAKURA) and cut to 8 μm thickness with a cryostat (Leica CM1950).</p></sec><sec id="s4-4"><title>CRISPRa and CRISPRi assay</title><p>CRISPR/dCas9-mediated transcription activation (CRISPRa) and CRISPR/dCas9-mediated transcription interference (CRISPRi) assay were performed as previously described (<xref ref-type="bibr" rid="bib69">Wang et al., 2022</xref>). In brief, single-guide RNAs (sgRNAs) were designed using online tool (<ext-link ext-link-type="uri" xlink:href="https://zlab.bio/guide-design-resources">https://zlab.bio/guide-design-resources</ext-link>) and were listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. sgRNAs were cloned into lenti sgRNA (MS2)_zeo backbone vector (Addgene, #61427). For CRISPRi assays, pHR-SFFV-dCas9-BFP-KRAB (Addgene, #46911) is used. For CRISPRa assays, lenti MS2-P65-HSF1_Hygro (Addgene, #61426) and dCAS9-VP64_GFP (Addgene, #61422) were used. To obtain lentiviral particles, HEK293T cells (5×10<sup>6</sup> cells per 10 cm dish) were transiently transfected with 12 μg CRISPRa or CRISPRi constructs, 6 μg psPAX2, and 6 μg pMD2.G. The supernatant containing lentivirus particles was harvested at 72 hr after transfection and filtered through Millex-GP Filter Unit (0.45 μm pore size, Millipore). To obtain high virus titer, the supernatant was centrifuged at 10,000×<italic>g</italic> for 100 min and concentrate to 100 μl. On the day before infection, HCT-15 cells (2×10<sup>5</sup> cells per well) were inoculated in 12-well plates. 10 μl high titer viruses were added to each well. 72 hr after infection, cells were harvested for RT-qPCR analysis.</p></sec><sec id="s4-5"><title>RNA isolation and cDNA synthesis</title><p>RNAiso Plus (TAKARA) is used for RNA isolation. 1 ml RNAiso Plus was added to DNase/RNase free EP tube to lyse tissues or cells, followed by adding one-fifth volume of chloroform to achieve phase separation. After vigorous shaking, centrifuge at 12,000×<italic>g</italic> for 15 min at 4°C. The upper aqueous phase was transferred to a new DNase/RNase-free EP tube and equal volume of isopropanol was added to precipitate RNA. Precipitation was dissolved in DNase/RNase-free water. Complementary DNAs (cDNAs) were synthesized by HiScript II Q RT SuperMix for qPCR kit (Vazyme; R222-01).</p></sec><sec id="s4-6"><title>Real-time RT-qPCR</title><p>cDNA was subjected to RT-qPCR using the SYBR Green assay with 2× SYBR Green qPCR master mix (Bimake). PCRs were performed on a CFX Connect Real-Time PCR Detection System (Bio-Rad) under the following condition: 5 min at 95°C, 40 cycles at 95°C for 15 s, 60°C for 20 s. The relative transcript level of each gene was normalized to <italic>Gapdh</italic> (mice) or <italic>ACTB</italic> (human) and calculated according to the 2<sup>-ΔΔCt</sup> method. All primers used are shown in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-7"><title>Isolation of murine intestinal crypt cells</title><p>Murine small intestines were harvested and cut open longitudinally. After three times wash in cold PBS with penicillin (200 U/ml)+streptomycin (200 μg/ml) (Invitrogen), small intestines were cut into 5 cm segments and incubated in pre-cold PBS with 8 mM EDTA at 4°C for 2 hr. Then intestinal tissues were transferred into a centrifuge tube filled with new cold PBS. Shake vigorously for 5 min and collect intestinal epithelial cells (villi plus crypts) from the supernatant. Centrifuge the supernatant to collect all epithelial cells or pass through 70 μm cell filter (Corning) to filter out villi. Crypts were spun down in a centrifuge at 300×<italic>g</italic> for 5 min.</p></sec><sec id="s4-8"><title>Enriching <italic>Lgr5</italic>-EGFP<sup>+</sup> cells</title><p>Crypts were collected from <italic>Lgr5</italic>-EGFP and <italic>H11<sup>i.enh</sup>;Lgr5</italic>-EGFP mice, followed by resuspension and single-cell digestion in DMEM containing 0.25% trypsin (Gibco) at 37°C for 5 min. Disaggregated cells were passed through 40 μm cell strainers (Corning). <italic>Lgr5</italic>-EGFP<sup>+</sup> and <italic>Lgr5</italic>-EGFP<sup>-</sup> cells were collected using a BD Arial III cell sorter.</p></sec><sec id="s4-9"><title>X-Gal staining</title><p>X-Gal staining is performed as described (<xref ref-type="bibr" rid="bib69">Wang et al., 2022</xref>). In short, frozen slides were placed in fixed buffer (0.2% PFA, 0.1 M PIPES buffer [pH 6.9], 2 mM MgCl<sub>2</sub>, 5 mM EGTA) for 10 min, followed by rinse for two times with PBS containing 2 mM MgCl<sub>2</sub>. Then slides were incubated with detergent solution (0.1 M PBS [pH 7.3], 2 mM MgCl<sub>2</sub>, 0.01% sodium deoxycholate, 0.02% Nonidet P-40) for 10 min. Slides were incubated with freshly prepared and filtered X-Gal staining solution (0.1 M PBS [pH 7.3], 2 mM MgCl<sub>2</sub>, 0.01% sodium-deoxycholate, 0.02% Nonidet P-40, 5 mM K<sub>3</sub>Fe(CN)<sub>6</sub>, 5 mM K<sub>4</sub>Fe(CN)<sub>6</sub>·3H<sub>2</sub>O, and 1 mg/ml X-Gal) overnight in the dark at 37°C. For whole GI tissues, tissues were fixed in freshly prepared 4% PFA for 10 min, followed by rinse with detergent solution for 5 min by three times. Tissues were incubated with freshly prepared and filtered X-Gal staining solution at 37°C for a few hours.</p></sec><sec id="s4-10"><title>EdU pulse-labeling experiment</title><p>Mice were intraperitoneally injected with EdU (10 mg/kg of body weight). After 4 hr, harvest the intestines for frozen sectioning. Staining was performed using BeyoClick EdU Cell Promotion Kit (C0075S, Beyotime, China) according to the manufacturer’s manual.</p></sec><sec id="s4-11"><title>ChIP-qPCR assay</title><p>Cells were crosslinked with 1% formaldehyde for 10 min at room temperature and then quenched with 0.125 M glycine for 5 min and washed twice with cold PBS. Cells were resuspended with 500 μl lysis buffer (50 mM Tris-HCl, pH 8.0, 0.5% SDS, 5 mM EDTA) and subjected to sonication on ice with an output power of 100 W, 12 min, 0.5 s on, 0.5 s off. After centrifugation, 1% of the supernatant was taken out as input. The DNA fragment lengths were measured by gel electrophoresis, showing fragments between 200 bp and 500 bp, with an average length around 300 bp. The rest of the sonicated lysates was diluted into 0.1% SDS and divided into several equal parts. Immunoprecipitation was performed overnight at 4°C on a rotating wheel with sheared chromatin, protein G agarose beads, and indicated antibodies: 2 μg HNF4α (Abcam, ab181604), 2 μg p-S133-CREB1 (Abcam, ab32096), 2 μg IgG antibody (ABclonal, AC005). The next day, beads were cleaned three times with Wash Buffer I (20 mM Tris-HCl, pH 8.0; 1% Triton X-100; 2 mM EDTA; 150 mM NaCl; 0.1% SDS), Wash Buffer II (20 mM Tris-HCl, pH 8.0; 1% Triton X-100; 2 mM EDTA; 500 mM NaCl; 0.1% SDS), Wash Buffer III (10 mM Tris-HCl, pH 8.0; 1 mM EDTA; 0.25 M LiCl; 1% NP-40; 1% deoxycholate), and TE buffer. Protein-DNA complexes were de-crosslinked in 120 μl elution buffer (0.1 M NaHCO<sub>3</sub>, 1% SDS, 20 µg/ml proteinase K) and shaken at 65°C overnight. DNA purification kit (TIANGEN) was used to extract DNA fragments for qPCR.</p><p>The efficiency of qPCR primers was evaluated using gradient diluted (10<sup>0</sup>, 10<sup>–1</sup>, 10<sup>–2</sup>, 10<sup>–3</sup>, 10<sup>–4</sup>, 10<sup>–5</sup>) of mouse or human genomes as templates. After completing qPCR, the dilution factors were plotted on the X-axis using log10 values, and the corresponding Ct value was plotted on the Y-axis to create a standard curve. The equation y=kx + b was derived, and the primer efficiency was calculated using the formula E=10^(–1/k) – 1. The results indicated that the primer efficiency ranged from 90% to 110%, with no significant differences observed.</p></sec><sec id="s4-12"><title>Luciferase reporter assay</title><p>The luciferase reporter assay was performed as described previously (<xref ref-type="bibr" rid="bib34">Li et al., 2017</xref>). Briefly, the CR of ieCtnnb1, five regions of ieCTNNB1, and the region containing the mutation site were respectively cloned into pGL3-promoter vector (Promega). HEK293T, HeLa, and HCT116 cells were transfected with pGL3-promoter vector and the plasmids mentioned above. <italic>Renilla</italic> basic vector was co-transfected as a control for normalization of luciferase activity. After 48 hr of transfection, Promega Dual Glo test kit (Promega, E1910) was used to measure luciferase activity according to the manufacturer’s instructions.</p></sec><sec id="s4-13"><title>IHC staining</title><p>Frozen sections were dried at 37°C, fixed with 4% PFA for 10 min, and then washed three times with PBS. Antigen retrieval was performed using citrate buffer (pH 6, epitope retrieval solution) at 95°C for 20 min. Slides were then placed in 3% H<sub>2</sub>O<sub>2</sub> solution for a few hours to remove endogenous catalase. After washing with PBS three times, slides were blocked with 10% normal goat serum for 1 hr, then incubated with the following primary antibodies overnight at 4°C: rabbit anti-α-defensin5 (Abcam, ab80515, 1:500), rabbit anti-Ki67 (Abcam, ab15580, 1:500), rabbit anti-β-catenin (Cell Signaling Technology, 8480T, 1:100), rabbit anti-Muc2 (Thermo Fisher Scientific, PA5-21329, 1:500). The next day, slides were incubated with biotin-labeled secondary antibodies at room temperature for 1 hr. Then, slides were incubated with the avidin-biotin-peroxidase complex (VECTASTAIN Elite ABC system, Vector Labs). Finally, colorization was performed in the reaction solution (Tris-HCl [pH 7.2], 5 mg/ml 3,3'-diaminobenzidine, 0.075% H<sub>2</sub>O<sub>2</sub>).</p></sec><sec id="s4-14"><title>H&amp;E staining</title><p>H&amp;E staining kit (Beyotime Biotech, C0105S) was used for experiments. Frozen slides were dried at 65°C, then dripped with hematoxylin staining solution for 5 min. Excess staining solution was rinsed off with water. Slides were immersed in distilled water for 5 min, then rinsed with 95% ethanol, and stained with eosin solution for 30 s. Subsequently, slides were put into anhydrous ethanol for 2 min, and cleared with xylene for 5 min. After air dry, slides were sealed with neutral resin.</p></sec><sec id="s4-15"><title>Immunoblotting analysis</title><p>Crypt cells were lysed by 1× SDS loading buffer at 95°C for 10 min. After short centrifugation, the supernatants were loaded onto 10% SDS-polyacrylamide gel electrophoresis gels. Then, proteins were transferred onto polyvinylidene fluoride membrane (Millipore). Membranes were blocked with 10% non-fat milk in Tris-buffered saline containing 0.3% Tween 20 (TBST; pH 7.4) for 1 hr at room temperature. Immunoblotting was carried out us primary antibody: rabbit anti-β-catenin (Cell Signaling Technology, 8480T, 1:100); mouse anti-GAPDH (ABclonal, AC001, 1:1000); rabbit anti-H3 (ABclonal, A2348, 1:10,000). After three times of washing with TBST, the membrane was incubated with anti-rabbit immunoglobulin G (IgG)-conjugated horseradish peroxidase secondary for 1 hr at room temperature. Signals were detected using the ECL substrate (Thermo Fisher Scientific).</p></sec><sec id="s4-16"><title>Alcian Blue PAS staining</title><p>Alcian Blue PAS Stain Kit (Abcam, ab245876) was used for experiments. All materials and prepared reagents were equilibrated to room temperature and gently agitated prior to use. Tissue sections were applied with acetic acid solution (3%) for 2 min. Then Alcian Blue solution (pH 2.5) was applied for 15–20 min. Slides were rinsed with running tap water for 2 min followed by two changes of distilled water. Periodic acid solution was applied to tissue sections for 5 min. After slides were rinsed with two changes of distilled water, Schiff’s solution was applied to tissue sections for 10–20 min. Slides were rinsed with warm running tap water for 2 min followed by two changes of distilled water. Tissue sections were applied with hematoxylin for 2 min. Sections were rinsed in running tap water for 2 min followed by two changes of distilled water. Slides were dehydrated through graded alcohols and sealed with synthetic resin.</p></sec><sec id="s4-17"><title>Cell sorting</title><p>Crypt single cells were prepared as described above. Enrichment of epithelial cells by cell sorting was carried out according to reported protocols with slight modification (<xref ref-type="bibr" rid="bib24">Haber et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Huang et al., 2022</xref>). Cells were resuspended using 1 ml PBS and stained with 5 μl anti-EpCAM-FITC (eBioScience, 11-5791-82) at 4°C for 30 min. After washing with PBS three times, cells were resuspended using 1 M FACS buffer (PBS with 1% BSA) containing 0.2 μg/ml DAPI (BD Pharmingen, Cat. No. 564907). Cells were filtered with nylon membrane with a 40 μm pore size. EpCAM positive cells were sorted and collected based on fluorescence signals for subsequent single-cell sequencing. Flow cytometry data were acquired on a BD Arial III flow cytometer and analyzed with FlowJo (version 10.6.2).</p></sec><sec id="s4-18"><title>Bulk RNA-seq</title><p>RNA-seq and data analyses were performed at Novogene Co., Ltd (Beijing, China). Crypt cells or tumor tissues were harvested and total RNAs were extracted. RNA integrity was assessed using the RNA Nano 6000 Assay Kit of the Bioanalyzer 2100 system (Agilent Technologies, CA, USA). RNA-seq library construction was performed as described previously (<xref ref-type="bibr" rid="bib71">Xu et al., 2021</xref>). Briefly, first strand cDNA was synthesized using random hexamer primer and M-MuLV Reverse Transcriptase (RNase H-). Second strand cDNA synthesis was subsequently performed using DNA Polymerase I and RNase H. Then, the library fragments were purified with AMPure XP system (Beckman Coulter, Beverly, MA, USA). Then PCR was performed with Phusion High-Fidelity DNA polymerase, Universal PCR primers, and Index (X) Primer. At last, PCR products were purified (AMPure XP system). The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq PE Cluster Kit v3-cBot-HS (Illumina) according to the manufacturer’s instructions. After cluster generation, the library preparations were sequenced on an Illumina Novaseq platform and 150 bp paired-end reads were generated.</p></sec><sec id="s4-19"><title>Bulk RNA-seq data processing</title><p>For data analysis, raw data of fastq format were first processed through in-house perl scripts. In this step, clean data were obtained by removing reads containing adapter, reads containing poly-N (indicating bases that were not detected and hence signal-free), and low-quality reads from the raw data. Index of the reference genome was built using Hisat2 v2.0.5 and paired-end clean reads were aligned to the reference genome using Hisat2 v2.0.5. featureCounts v1.5.0-p3 was used to count reads numbers mapped to each gene. Differential expression analysis of two groups was performed using the DESeq2 R package (1.20.0). The resulting p-values were adjusted using the Benjamini and Hochberg’s approach for controlling the false discovery rate. Genes with an adjusted p-value&lt;0.05 found by DESeq2 were assigned as differentially expressed. GO enrichment analysis of differentially expressed genes was implemented by the clusterProfiler R package, in which gene length bias was corrected. clusterProfiler R package was also used to test the statistical enrichment of differential expression genes in KEGG pathways. Local version of the GSEA tool (<ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/gsea/index.jsp">http://www.broadinstitute.org/gsea/index.jsp</ext-link>), GO, KEGG, Reactome, DO, and DisGeNET datasets were used for GSEA independently.</p></sec><sec id="s4-20"><title>Single-cell RNA-seq and data analysis</title><p>Single-cell RNA-seq (scRNA-seq) and data analysis were performed at Novogene Co., Ltd (Beijing, China). The protoplast suspension was loaded into Chromium microfluidic chips with 30 chemistry (v2 or v3) and barcoded with a 10× Chromium Controller (10X Genomics). RNA from the barcoded cells was subsequently reverse-transcribed and sequencing libraries constructed with reagents from a Chromium Single Cell 30 v2 reagent kit (10X Genomics) according to the manufacturer’s instructions. Sequencing was performed with Illumina HiSeq 2000 according to the manufacturer’s instructions. For data analysis, we use FastQC to perform basic statistics on the quality of the raw reads. Raw reads were demultiplexed and mapped to the reference genome by 10X Genomics Cell Ranger pipeline using default parameters. All downstream single-cell analyses were performed using CellRanger and Seurat unless mentioned specifically. In brief, for each gene and each cell barcode (filtered by CellRanger), unique molecule identifiers were counted to construct digital expression matrices. Secondary filtration by Seurat: a gene with expression in more than three cells was considered as expressed, and each cell was required to have at least 200 expressed genes.</p></sec><sec id="s4-21"><title>Hi-C data analysis</title><p>Hi-C data analysis completed by Frasergen Medicine Co., Ltd (Wuhan, China). Hi-C data of BALB/c mice large intestinal epithelial cells were provided by Dr. Gen Zheng (<xref ref-type="bibr" rid="bib78">Zheng et al., 2023</xref>). The Hi-C data of SW480 cells was obtained from deposited data (<xref ref-type="bibr" rid="bib50">Orouji et al., 2022</xref>). According to the reported method, the dynamic changes of TAD structures can be explored by calculating the relative signal values of TAD boundaries. TAD boundaries that are common among individuals and are not within the 2 Mb range of chromosomal ends were included, followed by filtering out boundaries with interactions less than 10 in the 2 Mb upstream and downstream regions. The ratio of the interaction between the boundary and its 2 Mb upstream and downstream regions were calculated using log2 to obtain the signal value of the TAD boundary, then the minimum value was subtracted from it to finally obtain the distribution of the relative signal value of each sample TAD boundary.</p></sec><sec id="s4-22"><title>ChIP-seq data analysis</title><p>The human CRC patient RNA-seq FPKM files and ChIP-seq data were from GEO dataset GSE156614 (<xref ref-type="bibr" rid="bib35">Li et al., 2021a</xref>). All ChIP-seq raw fastq data were removed of adaptor sequence. Cutadapt (version 1.16) was used with the parameters -u 3 -u -10 -U 3 -U -10 -m 30. Cleaned reads were aligned to the human reference genome (hg19) using bowtie2 (version 2.4.4) with default settings. The CrossMap (0.6.5) package was used as a conversion between different versions of the human genome (hg19 and hg38). We calculated the normalized RPM (reads per million mapped reads) of ChIP-seq signal at ieCTNNB1 and <italic>CTNNB1</italic> promoter. Briefly, reads aligned to the specified region were calculated with bedtools multicov command. These reads were normalized with RPM. RNA-seq data FPKM (reads per kilobase per million mapped reads) were converted to TPM (transcript per kilobase per million mapped reads) using R version 4.2.3.</p></sec><sec id="s4-23"><title>Knockdown experiments</title><p>Target sequences for shRNAs were designed on the Merck Life Sciences website (<ext-link ext-link-type="uri" xlink:href="https://www.sigmaaldrich.cn">https://www.sigmaaldrich.cn</ext-link>) and were listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Oligonucleotides for shRNAs were cloned into pLKO.1 vector (Addgene, #21297). The day before transfection, HEK293T cells (2×10<sup>5</sup> cells per well) were seeded in 12-well plates. pLKO.1 constructs, psPAX2, and pMD2.G were co-transfected into HEK293T cells. After 72 hr, supernatant containing virus particles was harvested and passed through Millex-GP Filter Unit (0.45 μm pore size, Millipore). Viral particles were aliquoted and stored at –80°C. On the day before infection, HCT-15 cells (2×10<sup>5</sup> cells per well) were seeded in 12-well plates. 20 μl virus suspension were added to each well. After 72 hr, cells were harvested for RT-qPCR to evaluate knockdown efficiency.</p></sec><sec id="s4-24"><title>Reference database</title><p>ChIP-seq signals for H3K27ac, H3K4me3, H3K4me1, H3K36me3, and DNase I hypersensitivity data of stomach, intestines, liver, and other tissues at different stages were downloaded from the ENCODE (<ext-link ext-link-type="uri" xlink:href="https://www.encodeproject.org/">https://www.encodeproject.org/</ext-link>) and their identifiers are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. In addition, ChIP-seq data for listed TFs of cells or tissues were obtained from Cistrome Data Browser (<ext-link ext-link-type="uri" xlink:href="http://cistrome.org">http://cistrome.org</ext-link>). Expressions of <italic>HNF4A</italic> and <italic>CREB1</italic> in human colon (COAD) and rectal (READ) cancers were obtained from GEPIA (gepia.cancer-pku.cn).</p></sec><sec id="s4-25"><title>eQTL analysis</title><p>The GTEX database (<ext-link ext-link-type="uri" xlink:href="https://www.gtexportal.org/home/">https://www.gtexportal.org/home/</ext-link>) was used to search SNPs at <italic>CTNNB1</italic> and the 1 MB upstream and downstream region, followed by eQTL analysis. A variant, rs115981379 (C&gt;T), was identified inside <italic>CTNNB1</italic>. The expression levels of <italic>CTNNB1</italic> in 428 C/C type and 37 C/T type esophagus samples, and 343 C/C type and 25 C/T type transverse colon samples were also obtained in the GTEX database.</p></sec><sec id="s4-26"><title>Analyses of HNF4α and CREB1 binding motifs</title><p>The JASPAR database (<ext-link ext-link-type="uri" xlink:href="https://jaspar.elixir.no/">https://jaspar.elixir.no/</ext-link>) was used to analyze binding motifs of HNF4α and CREB1 at ieCtnnb1<italic>/</italic>ieCTNNB1 and <italic>Ctnnb1/CTNNB1</italic> promoter. Results are listed in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec><sec id="s4-27"><title>Nuclear-cytoplasmic separation</title><p>Nuclear and cytoplasmic protein extraction kit (Beyotime Biotech, P0027) was used for experiments. Small intestinal crypts were collected from wild-type and <italic>Ctnnb1<sup>Δi.enh</sup></italic> mice as described above. According to the manufacturer’s instructions, 20 μl cell precipitation was resuspended in 200 μl cytoplasmic protein extraction reagent A with 1 mM PMSF. After placing on ice for 15 min, 10 μl cytoplasmic protein extraction reagent B was added. After vigorous vortex, solutions were centrifuged at 12,000×<italic>g</italic> for 5 min at 4°C. The supernatant was collected as the extracted cytoplasmic protein. The precipitate was resuspended with 50 μl nuclear protein extraction reagent with 1 mM PMSF. Solutions were placed on ice and vortex vigorously every 2 min for a total of 30 min. After centrifuging at 12,000×<italic>g</italic> for 10 min at 4°C, the supernatant was collected as the extracted nuclear protein.</p></sec><sec id="s4-28"><title>Statistics</title><p>All experiments reported in this study were repeated at least three independent times. In vivo analyses were conducted with at least three animals per condition. The number of animals in each experiment is depicted in Figure legends. The signal intensity of tumor stain region was generated using ImageJ software (version 6.0.0.260) as described previously (<xref ref-type="bibr" rid="bib68">Wang et al., 2021</xref>). GraphPad Prism (version 8.0.2) was used to determine statistical significance. Unpaired two-tailed Student’s <italic>t</italic>-test were used for analysis between two groups of equal variances by <italic>F-</italic>tests. When the <italic>F-</italic>test of equal variance failed, the Welch <italic>t</italic>-tests were used. Data comparison of three or more groups with control groups were analyzed using one-way ANOVA followed by Dunnett’s multiple comparison test. Data comparison of three or more groups among each other were analyzed using one-way ANOVA followed by Tukey’s multiple comparison test. The exact p-values were reported in each figure or indicated as ****, p&lt;0.0001; ***, p&lt;0.001; **, p&lt;0.01; *, p&lt;0.05, ns = not significant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Visualization, Methodology, Writing – original draft, Performed experiments and analyzed data</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Processed ChIP-seq data</p></fn><fn fn-type="con" id="con3"><p>Methodology, Retrieved and analyzed eQTL data</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology, Performed experiments and analyzed data</p></fn><fn fn-type="con" id="con5"><p>Methodology, Retrieved and analyzed eQTL data</p></fn><fn fn-type="con" id="con6"><p>Resources, Provided Hi-C data</p></fn><fn fn-type="con" id="con7"><p>Resources, Provided RNA-seq and ChIP-seq data of colorectal cancer samples</p></fn><fn fn-type="con" id="con8"><p>Resources, Provided RNA-seq and ChIP-seq data of colorectal cancer samples</p></fn><fn fn-type="con" id="con9"><p>Supervision, Funding acquisition, Provided funding and supervised the study</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Writing – original draft, Project administration, Conceived and designed the study, provided funding and supervised the study and wrote the paper</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal procedures were approved by the Animal Care and Ethical Committee of Medical Research Institute at Wuhan University (Permit Number: MRI2019-LAC46, MRI2021-LAC27 and MRI2022-LAC151). All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primers used in this study.</title></caption><media xlink:href="elife-98238-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Summary of high-throughput data used in this study.</title></caption><media xlink:href="elife-98238-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>HNF4α and CREB1 motifs analyses at ieCtnnb1<italic>/</italic>ieCTNNB1 and <italic>Ctnnb1/CTNNB1</italic> promoter.</title></caption><media xlink:href="elife-98238-supp3-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-98238-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The GEO accession number for the bulk RNA-seq and scRNA-seq data reported in this paper is GSE233979. Custom codes are described in detail at methods section.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Miao</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Ye</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Wnt signaling dosage controlled by a Ctnnb1 enhancer balances homeostasis and tumorigenesis of intestinal epithelia</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE233979">GSE233979</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Yeguang Chen for providing the <italic>Lgr5</italic>-EGFP-IRES-CreERT2 mice. We thank the Core Facility and the Animal Facility of Medical Research Institute of Wuhan University for technical support. We thank all Zhou lab members for critical reading of the manuscript. Y Zhou was supported by grants from National Key R&amp;D Program of China (2022YFA0806603 and 2018YFA0800700), National Natural Science Foundation of China (32270876 and 31970770), and the Fundamental Research Funds for the Central Universities (2042022dx0003 and 2042023kf0234). Y Liu was supported by grants from National Natural Science Foundation of China (32470776 and 31970770), National Key R&amp;D Program of China (2018YFA0800700 and 2022YFA0806603), and Hubei Natural Science Foundation (2022CFB128).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreu</surname><given-names>P</given-names></name><name><surname>Peignon</surname><given-names>G</given-names></name><name><surname>Slomianny</surname><given-names>C</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Colnot</surname><given-names>S</given-names></name><name><surname>Robine</surname><given-names>S</given-names></name><name><surname>Lamarque</surname><given-names>D</given-names></name><name><surname>Laurent-Puig</surname><given-names>P</given-names></name><name><surname>Perret</surname><given-names>C</given-names></name><name><surname>Romagnolo</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation</article-title><source>Developmental Biology</source><volume>324</volume><fpage>288</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.09.027</pub-id><pub-id pub-id-type="pmid">18948094</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>CD</given-names></name><name><surname>Gerlach</surname><given-names>D</given-names></name><name><surname>Stelzer</surname><given-names>C</given-names></name><name><surname>Boryń</surname><given-names>ŁM</given-names></name><name><surname>Rath</surname><given-names>M</given-names></name><name><surname>Stark</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome-wide quantitative enhancer activity maps identified by STARR-seq</article-title><source>Science</source><volume>339</volume><fpage>1074</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1126/science.1232542</pub-id><pub-id pub-id-type="pmid">23328393</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayyaz</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Sangiorgi</surname><given-names>B</given-names></name><name><surname>Ghoshal</surname><given-names>B</given-names></name><name><surname>Gosio</surname><given-names>J</given-names></name><name><surname>Ouladan</surname><given-names>S</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name><name><surname>Barutcu</surname><given-names>S</given-names></name><name><surname>Trcka</surname><given-names>D</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Wrana</surname><given-names>JL</given-names></name><name><surname>Gregorieff</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell</article-title><source>Nature</source><volume>569</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1154-y</pub-id><pub-id pub-id-type="pmid">31019301</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>ERM</given-names></name><name><surname>Hoekstra</surname><given-names>E</given-names></name><name><surname>Franken</surname><given-names>PF</given-names></name><name><surname>Helvensteijn</surname><given-names>W</given-names></name><name><surname>van Deurzen</surname><given-names>CHM</given-names></name><name><surname>van Veelen</surname><given-names>W</given-names></name><name><surname>Kuipers</surname><given-names>EJ</given-names></name><name><surname>Smits</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>β-Catenin signaling dosage dictates tissue-specific tumor predisposition in Apc-driven cancer</article-title><source>Oncogene</source><volume>32</volume><fpage>4579</fpage><lpage>4585</lpage><pub-id pub-id-type="doi">10.1038/onc.2012.449</pub-id><pub-id pub-id-type="pmid">23045279</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>Kuipers</surname><given-names>J</given-names></name><name><surname>Kujala</surname><given-names>P</given-names></name><name><surname>van den Born</surname><given-names>M</given-names></name><name><surname>Cozijnsen</surname><given-names>M</given-names></name><name><surname>Haegebarth</surname><given-names>A</given-names></name><name><surname>Korving</surname><given-names>J</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><name><surname>Peters</surname><given-names>PJ</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Identification of stem cells in small intestine and colon by marker gene Lgr5</article-title><source>Nature</source><volume>449</volume><fpage>1003</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1038/nature06196</pub-id><pub-id pub-id-type="pmid">17934449</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barreto</surname><given-names>EBL</given-names></name><name><surname>Rattes</surname><given-names>IC</given-names></name><name><surname>da Costa</surname><given-names>AV</given-names></name><name><surname>Gama</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Paneth cells and their multiple functions</article-title><source>Cell Biology International</source><volume>46</volume><fpage>701</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1002/cbin.11764</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beumer</surname><given-names>J</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulation and plasticity of intestinal stem cells during homeostasis and regeneration</article-title><source>Development</source><volume>143</volume><fpage>3639</fpage><lpage>3649</lpage><pub-id pub-id-type="doi">10.1242/dev.133132</pub-id><pub-id pub-id-type="pmid">27802133</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beumer</surname><given-names>J</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cell fate specification and differentiation in the adult mammalian intestine</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>22</volume><fpage>39</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0278-0</pub-id><pub-id pub-id-type="pmid">32958874</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlezon</surname><given-names>WA</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The many faces of CREB</article-title><source>Trends in Neurosciences</source><volume>28</volume><fpage>436</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2005.06.005</pub-id><pub-id pub-id-type="pmid">15982754</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattin</surname><given-names>AL</given-names></name><name><surname>Le Beyec</surname><given-names>J</given-names></name><name><surname>Barreau</surname><given-names>F</given-names></name><name><surname>Saint-Just</surname><given-names>S</given-names></name><name><surname>Houllier</surname><given-names>A</given-names></name><name><surname>Gonzalez</surname><given-names>FJ</given-names></name><name><surname>Robine</surname><given-names>S</given-names></name><name><surname>Pinçon-Raymond</surname><given-names>M</given-names></name><name><surname>Cardot</surname><given-names>P</given-names></name><name><surname>Lacasa</surname><given-names>M</given-names></name><name><surname>Ribeiro</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium</article-title><source>Molecular and Cellular Biology</source><volume>29</volume><fpage>6294</fpage><lpage>6308</lpage><pub-id pub-id-type="doi">10.1128/MCB.00939-09</pub-id><pub-id pub-id-type="pmid">19805521</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer</article-title><source>Biomedicine &amp; Pharmacotherapy = Biomedecine &amp; Pharmacotherapie</source><volume>110</volume><fpage>473</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.11.082</pub-id><pub-id pub-id-type="pmid">30530050</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>AM</given-names></name><name><surname>Hill</surname><given-names>DR</given-names></name><name><surname>Aurora</surname><given-names>M</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Morphogenesis and maturation of the embryonic and postnatal intestine</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>66</volume><fpage>81</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.01.011</pub-id><pub-id pub-id-type="pmid">28161556</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Wnt/beta-catenin signaling in development and disease</article-title><source>Cell</source><volume>127</volume><fpage>469</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.10.018</pub-id><pub-id pub-id-type="pmid">17081971</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Wnt/β-catenin signaling and disease</article-title><source>Cell</source><volume>149</volume><fpage>1192</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.05.012</pub-id><pub-id pub-id-type="pmid">22682243</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The intestinal crypt, a prototype stem cell compartment</article-title><source>Cell</source><volume>154</volume><fpage>274</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.07.004</pub-id><pub-id pub-id-type="pmid">23870119</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Loh</surname><given-names>KM</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control</article-title><source>Science</source><volume>346</volume><elocation-id>1248012</elocation-id><pub-id pub-id-type="doi">10.1126/science.1248012</pub-id><pub-id pub-id-type="pmid">25278615</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degirmenci</surname><given-names>B</given-names></name><name><surname>Valenta</surname><given-names>T</given-names></name><name><surname>Dimitrieva</surname><given-names>S</given-names></name><name><surname>Hausmann</surname><given-names>G</given-names></name><name><surname>Basler</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>GLI1-expressing mesenchymal cells form the essential Wnt-secreting niche for colon stem cells</article-title><source>Nature</source><volume>558</volume><fpage>449</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0190-3</pub-id><pub-id pub-id-type="pmid">29875413</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>A</given-names></name><name><surname>Donahue</surname><given-names>B</given-names></name><name><surname>Peignon</surname><given-names>G</given-names></name><name><surname>Letourneur</surname><given-names>F</given-names></name><name><surname>Cagnard</surname><given-names>N</given-names></name><name><surname>Slomianny</surname><given-names>C</given-names></name><name><surname>Perret</surname><given-names>C</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>Romagnolo</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Functional intestinal stem cells after Paneth cell ablation induced by the loss of transcription factor Math1 (Atoh1)</article-title><source>PNAS</source><volume>109</volume><fpage>8965</fpage><lpage>8970</lpage><pub-id pub-id-type="doi">10.1073/pnas.1201652109</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garabedian</surname><given-names>EM</given-names></name><name><surname>Roberts</surname><given-names>LJ</given-names></name><name><surname>McNevin</surname><given-names>MS</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>23729</fpage><lpage>23740</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.38.23729</pub-id><pub-id pub-id-type="pmid">9295317</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrison</surname><given-names>WD</given-names></name><name><surname>Battle</surname><given-names>MA</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Sladek</surname><given-names>FM</given-names></name><name><surname>Duncan</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon</article-title><source>Gastroenterology</source><volume>130</volume><fpage>1207</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2006.01.003</pub-id><pub-id pub-id-type="pmid">16618389</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gribble</surname><given-names>FM</given-names></name><name><surname>Reimann</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Function and mechanisms of enteroendocrine cells and gut hormones in metabolism</article-title><source>Nature Reviews. Endocrinology</source><volume>15</volume><fpage>226</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1038/s41574-019-0168-8</pub-id><pub-id pub-id-type="pmid">30760847</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Kraiczy</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>PNP</given-names></name><name><surname>Ng</surname><given-names>C</given-names></name><name><surname>Dagdeviren</surname><given-names>S</given-names></name><name><surname>Houghton</surname><given-names>S</given-names></name><name><surname>Pellon-Cardenas</surname><given-names>O</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Banerjee</surname><given-names>KK</given-names></name><name><surname>Onufer</surname><given-names>EJ</given-names></name><name><surname>Warner</surname><given-names>BW</given-names></name><name><surname>Spence</surname><given-names>J</given-names></name><name><surname>Scherl</surname><given-names>E</given-names></name><name><surname>Rafii</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>RT</given-names></name><name><surname>Verzi</surname><given-names>MP</given-names></name><name><surname>Redmond</surname><given-names>D</given-names></name><name><surname>Longman</surname><given-names>R</given-names></name><name><surname>Helin</surname><given-names>K</given-names></name><name><surname>Shivdasani</surname><given-names>RA</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling</article-title><source>Cell Stem Cell</source><volume>29</volume><fpage>101</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2021.09.004</pub-id><pub-id pub-id-type="pmid">34582804</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustafsson</surname><given-names>JK</given-names></name><name><surname>Johansson</surname><given-names>MEV</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The role of goblet cells and mucus in intestinal homeostasis</article-title><source>Nature Reviews Gastroenterology &amp; Hepatology</source><volume>19</volume><fpage>785</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1038/s41575-022-00675-x</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haber</surname><given-names>AL</given-names></name><name><surname>Biton</surname><given-names>M</given-names></name><name><surname>Rogel</surname><given-names>N</given-names></name><name><surname>Herbst</surname><given-names>RH</given-names></name><name><surname>Shekhar</surname><given-names>K</given-names></name><name><surname>Smillie</surname><given-names>C</given-names></name><name><surname>Burgin</surname><given-names>G</given-names></name><name><surname>Delorey</surname><given-names>TM</given-names></name><name><surname>Howitt</surname><given-names>MR</given-names></name><name><surname>Katz</surname><given-names>Y</given-names></name><name><surname>Tirosh</surname><given-names>I</given-names></name><name><surname>Beyaz</surname><given-names>S</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Raychowdhury</surname><given-names>R</given-names></name><name><surname>Garrett</surname><given-names>WS</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Shi</surname><given-names>HN</given-names></name><name><surname>Yilmaz</surname><given-names>O</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A single-cell survey of the small intestinal epithelium</article-title><source>Nature</source><volume>551</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1038/nature24489</pub-id><pub-id pub-id-type="pmid">29144463</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname><given-names>FH</given-names></name><name><surname>Johnsen</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Perturbing enhancer activity in cancer therapy</article-title><source>Cancers</source><volume>11</volume><elocation-id>634</elocation-id><pub-id pub-id-type="doi">10.3390/cancers11050634</pub-id><pub-id pub-id-type="pmid">31067678</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>XT</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Xing</surname><given-names>S</given-names></name><name><surname>Tian</surname><given-names>JZ</given-names></name><name><surname>Ding</surname><given-names>YF</given-names></name><name><surname>Cai</surname><given-names>SL</given-names></name><name><surname>Yang</surname><given-names>YS</given-names></name><name><surname>Wood</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>JS</given-names></name><name><surname>Yang</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Embryogenic stem cell-derived intestinal crypt fission directs de novo crypt genesis</article-title><source>Cell Reports</source><volume>41</volume><elocation-id>111796</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.111796</pub-id><pub-id pub-id-type="pmid">36516755</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huels</surname><given-names>DJ</given-names></name><name><surname>Bruens</surname><given-names>L</given-names></name><name><surname>Hodder</surname><given-names>MC</given-names></name><name><surname>Cammareri</surname><given-names>P</given-names></name><name><surname>Campbell</surname><given-names>AD</given-names></name><name><surname>Ridgway</surname><given-names>RA</given-names></name><name><surname>Gay</surname><given-names>DM</given-names></name><name><surname>Solar-Abboud</surname><given-names>M</given-names></name><name><surname>Faller</surname><given-names>WJ</given-names></name><name><surname>Nixon</surname><given-names>C</given-names></name><name><surname>Zeiger</surname><given-names>LB</given-names></name><name><surname>McLaughlin</surname><given-names>ME</given-names></name><name><surname>Morrissey</surname><given-names>E</given-names></name><name><surname>Winton</surname><given-names>DJ</given-names></name><name><surname>Snippert</surname><given-names>HJ</given-names></name><name><surname>van Rheenen</surname><given-names>J</given-names></name><name><surname>Sansom</surname><given-names>OJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Wnt ligands influence tumour initiation by controlling the number of intestinal stem cells</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1132</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03426-2</pub-id><pub-id pub-id-type="pmid">29556067</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jindal</surname><given-names>GA</given-names></name><name><surname>Farley</surname><given-names>EK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Enhancer grammar in development, evolution, and disease: dependencies and interplay</article-title><source>Developmental Cell</source><volume>56</volume><fpage>575</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.02.016</pub-id><pub-id pub-id-type="pmid">33689769</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Escudero</surname><given-names>S</given-names></name><name><surname>Shivdasani</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Intact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cells</article-title><source>PNAS</source><volume>109</volume><fpage>3932</fpage><lpage>3937</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113890109</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krausova</surname><given-names>M</given-names></name><name><surname>Korinek</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Wnt signaling in adult intestinal stem cells and cancer</article-title><source>Cellular Signalling</source><volume>26</volume><fpage>570</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2013.11.032</pub-id><pub-id pub-id-type="pmid">24308963</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurokawa</surname><given-names>K</given-names></name><name><surname>Hayakawa</surname><given-names>Y</given-names></name><name><surname>Koike</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Plasticity of intestinal epithelium: stem cell niches and regulatory signals</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>357</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22010357</pub-id><pub-id pub-id-type="pmid">33396437</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kvon</surname><given-names>EZ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Kelman</surname><given-names>G</given-names></name><name><surname>Novak</surname><given-names>CS</given-names></name><name><surname>Plajzer-Frick</surname><given-names>I</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Garvin</surname><given-names>TH</given-names></name><name><surname>Pham</surname><given-names>Q</given-names></name><name><surname>Harrington</surname><given-names>AN</given-names></name><name><surname>Hunter</surname><given-names>RD</given-names></name><name><surname>Godoy</surname><given-names>J</given-names></name><name><surname>Meky</surname><given-names>EM</given-names></name><name><surname>Akiyama</surname><given-names>JA</given-names></name><name><surname>Afzal</surname><given-names>V</given-names></name><name><surname>Tran</surname><given-names>S</given-names></name><name><surname>Escande</surname><given-names>F</given-names></name><name><surname>Gilbert-Dussardier</surname><given-names>B</given-names></name><name><surname>Jean-Marçais</surname><given-names>N</given-names></name><name><surname>Hudaiberdiev</surname><given-names>S</given-names></name><name><surname>Ovcharenko</surname><given-names>I</given-names></name><name><surname>Dobbs</surname><given-names>MB</given-names></name><name><surname>Gurnett</surname><given-names>CA</given-names></name><name><surname>Manouvrier-Hanu</surname><given-names>S</given-names></name><name><surname>Petit</surname><given-names>F</given-names></name><name><surname>Visel</surname><given-names>A</given-names></name><name><surname>Dickel</surname><given-names>DE</given-names></name><name><surname>Pennacchio</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Comprehensive in vivo interrogation reveals phenotypic impact of human enhancer variants</article-title><source>Cell</source><volume>180</volume><fpage>1262</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.031</pub-id><pub-id pub-id-type="pmid">32169219</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kvon</surname><given-names>EZ</given-names></name><name><surname>Waymack</surname><given-names>R</given-names></name><name><surname>Gad</surname><given-names>M</given-names></name><name><surname>Wunderlich</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Enhancer redundancy in development and disease</article-title><source>Nature Reviews. Genetics</source><volume>22</volume><fpage>324</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/s41576-020-00311-x</pub-id><pub-id pub-id-type="pmid">33442000</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>K</given-names></name><name><surname>Zeng</surname><given-names>T</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells</article-title><source>Journal of Molecular Cell Biology</source><volume>9</volume><fpage>302</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1093/jmcb/mjx017</pub-id><pub-id pub-id-type="pmid">28486630</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>QL</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>YL</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>QX</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Cao</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>CY</given-names></name><name><surname>Huang</surname><given-names>CW</given-names></name><name><surname>Li</surname><given-names>LY</given-names></name><name><surname>Ye</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Genome-wide profiling in colorectal cancer identifies PHF19 and TBC1D16 as oncogenic super enhancers</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>6407</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-26600-5</pub-id><pub-id pub-id-type="pmid">34737287</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Chakravarti</surname><given-names>D</given-names></name><name><surname>Shalapour</surname><given-names>S</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>Genetic and biological hallmarks of colorectal cancer</article-title><source>Genes &amp; development</source><volume>35</volume><fpage>787</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1101/gad.348226</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YE</given-names></name><name><surname>Preissl</surname><given-names>S</given-names></name><name><surname>Hou</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Poirion</surname><given-names>OB</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Chiou</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Pinto-Duarte</surname><given-names>A</given-names></name><name><surname>Kubo</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>JY</given-names></name><name><surname>Lucero</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Kuan</surname><given-names>S</given-names></name><name><surname>Gorkin</surname><given-names>D</given-names></name><name><surname>Gaulton</surname><given-names>KJ</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Nunn</surname><given-names>M</given-names></name><name><surname>Mukamel</surname><given-names>EA</given-names></name><name><surname>Behrens</surname><given-names>MM</given-names></name><name><surname>Ecker</surname><given-names>JR</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021c</year><article-title>An atlas of gene regulatory elements in adult mouse cerebrum</article-title><source>Nature</source><volume>598</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03604-1</pub-id><pub-id pub-id-type="pmid">34616068</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Ning</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>YG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>33053</fpage><lpage>33058</lpage><pub-id pub-id-type="doi">10.1074/jbc.M804039200</pub-id><pub-id pub-id-type="pmid">18838381</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>KAI</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Knockdown of BAMBI inhibits β-catenin and transforming growth factor β to suppress metastasis of gastric cancer cells</article-title><source>Molecular Medicine Reports</source><volume>10</volume><fpage>874</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.3892/mmr.2014.2305</pub-id><pub-id pub-id-type="pmid">24912656</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lueschow</surname><given-names>SR</given-names></name><name><surname>McElroy</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The paneth cell: the curator and defender of the immature small intestine</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>587</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00587</pub-id><pub-id pub-id-type="pmid">32308658</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luis</surname><given-names>TC</given-names></name><name><surname>Naber</surname><given-names>BAE</given-names></name><name><surname>Roozen</surname><given-names>PPC</given-names></name><name><surname>Brugman</surname><given-names>MH</given-names></name><name><surname>de Haas</surname><given-names>EFE</given-names></name><name><surname>Ghazvini</surname><given-names>M</given-names></name><name><surname>Fibbe</surname><given-names>WE</given-names></name><name><surname>van Dongen</surname><given-names>JJM</given-names></name><name><surname>Fodde</surname><given-names>R</given-names></name><name><surname>Staal</surname><given-names>FJT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion</article-title><source>Cell Stem Cell</source><volume>9</volume><fpage>345</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2011.07.017</pub-id><pub-id pub-id-type="pmid">21982234</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mah</surname><given-names>AT</given-names></name><name><surname>Yan</surname><given-names>KS</given-names></name><name><surname>Kuo</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Wnt pathway regulation of intestinal stem cells</article-title><source>The Journal of Physiology</source><volume>594</volume><fpage>4837</fpage><lpage>4847</lpage><pub-id pub-id-type="doi">10.1113/JP271754</pub-id><pub-id pub-id-type="pmid">27581568</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mai</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>P</given-names></name><name><surname>Chu</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>BMP and activin membrane-bound inhibitor (BAMBI) inhibits the adipogenesis of porcine preadipocytes through Wnt/β-catenin signaling pathway</article-title><source>Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire</source><volume>92</volume><fpage>172</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1139/bcb-2014-0011</pub-id><pub-id pub-id-type="pmid">24798646</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maretto</surname><given-names>S</given-names></name><name><surname>Cordenonsi</surname><given-names>M</given-names></name><name><surname>Dupont</surname><given-names>S</given-names></name><name><surname>Braghetta</surname><given-names>P</given-names></name><name><surname>Broccoli</surname><given-names>V</given-names></name><name><surname>Hassan</surname><given-names>AB</given-names></name><name><surname>Volpin</surname><given-names>D</given-names></name><name><surname>Bressan</surname><given-names>GM</given-names></name><name><surname>Piccolo</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors</article-title><source>PNAS</source><volume>100</volume><fpage>3299</fpage><lpage>3304</lpage><pub-id pub-id-type="doi">10.1073/pnas.0434590100</pub-id><pub-id pub-id-type="pmid">12626757</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metcalfe</surname><given-names>C</given-names></name><name><surname>Kljavin</surname><given-names>NM</given-names></name><name><surname>Ybarra</surname><given-names>R</given-names></name><name><surname>de Sauvage</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration</article-title><source>Cell Stem Cell</source><volume>14</volume><fpage>149</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2013.11.008</pub-id><pub-id pub-id-type="pmid">24332836</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Tsuchiya</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision</article-title><source>Journal of Gastroenterology</source><volume>42</volume><fpage>705</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1007/s00535-007-2087-z</pub-id><pub-id pub-id-type="pmid">17876539</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalapareddy</surname><given-names>K</given-names></name><name><surname>Nattamai</surname><given-names>KJ</given-names></name><name><surname>Kumar</surname><given-names>RS</given-names></name><name><surname>Karns</surname><given-names>R</given-names></name><name><surname>Wikenheiser-Brokamp</surname><given-names>KA</given-names></name><name><surname>Sampson</surname><given-names>LL</given-names></name><name><surname>Mahe</surname><given-names>MM</given-names></name><name><surname>Sundaram</surname><given-names>N</given-names></name><name><surname>Yacyshyn</surname><given-names>MB</given-names></name><name><surname>Yacyshyn</surname><given-names>B</given-names></name><name><surname>Helmrath</surname><given-names>MA</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Geiger</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Canonical wnt signaling ameliorates aging of intestinal stem cells</article-title><source>Cell Reports</source><volume>18</volume><fpage>2608</fpage><lpage>2621</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.02.056</pub-id><pub-id pub-id-type="pmid">28297666</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noah</surname><given-names>TK</given-names></name><name><surname>Donahue</surname><given-names>B</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Intestinal development and differentiation</article-title><source>Experimental Cell Research</source><volume>317</volume><fpage>2702</fpage><lpage>2710</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2011.09.006</pub-id><pub-id pub-id-type="pmid">21978911</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusse</surname><given-names>R</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</article-title><source>Cell</source><volume>169</volume><fpage>985</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.016</pub-id><pub-id pub-id-type="pmid">28575679</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orouji</surname><given-names>E</given-names></name><name><surname>Raman</surname><given-names>AT</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Sorokin</surname><given-names>A</given-names></name><name><surname>Arslan</surname><given-names>E</given-names></name><name><surname>Ghosh</surname><given-names>AK</given-names></name><name><surname>Schulz</surname><given-names>J</given-names></name><name><surname>Terranova</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Maitituoheti</surname><given-names>M</given-names></name><name><surname>Callahan</surname><given-names>SC</given-names></name><name><surname>Barrodia</surname><given-names>P</given-names></name><name><surname>Tomczak</surname><given-names>K</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Davis</surname><given-names>JS</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>HM</given-names></name><name><surname>Reyes-Uribe</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Azhdarinia</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>J</given-names></name><name><surname>Vilar</surname><given-names>E</given-names></name><name><surname>Carmon</surname><given-names>KS</given-names></name><name><surname>Kopetz</surname><given-names>SE</given-names></name><name><surname>Rai</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer</article-title><source>Gut</source><volume>71</volume><fpage>938</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2020-322835</pub-id><pub-id pub-id-type="pmid">34059508</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pachano</surname><given-names>T</given-names></name><name><surname>Haro</surname><given-names>E</given-names></name><name><surname>Rada-Iglesias</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Enhancer-gene specificity in development and disease</article-title><source>Development</source><volume>149</volume><elocation-id>dev186536</elocation-id><pub-id pub-id-type="doi">10.1242/dev.186536</pub-id><pub-id pub-id-type="pmid">35686641</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pentinmikko</surname><given-names>N</given-names></name><name><surname>Iqbal</surname><given-names>S</given-names></name><name><surname>Mana</surname><given-names>M</given-names></name><name><surname>Andersson</surname><given-names>S</given-names></name><name><surname>Cognetta</surname><given-names>AB</given-names></name><name><surname>Suciu</surname><given-names>RM</given-names></name><name><surname>Roper</surname><given-names>J</given-names></name><name><surname>Luopajärvi</surname><given-names>K</given-names></name><name><surname>Markelin</surname><given-names>E</given-names></name><name><surname>Gopalakrishnan</surname><given-names>S</given-names></name><name><surname>Smolander</surname><given-names>OP</given-names></name><name><surname>Naranjo</surname><given-names>S</given-names></name><name><surname>Saarinen</surname><given-names>T</given-names></name><name><surname>Juuti</surname><given-names>A</given-names></name><name><surname>Pietiläinen</surname><given-names>K</given-names></name><name><surname>Auvinen</surname><given-names>P</given-names></name><name><surname>Ristimäki</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Tammela</surname><given-names>T</given-names></name><name><surname>Jacks</surname><given-names>T</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name><name><surname>Cravatt</surname><given-names>BF</given-names></name><name><surname>Yilmaz</surname><given-names>ÖH</given-names></name><name><surname>Katajisto</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Notum produced by Paneth cells attenuates regeneration of aged intestinal epithelium</article-title><source>Nature</source><volume>571</volume><fpage>398</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1383-0</pub-id><pub-id pub-id-type="pmid">31292548</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Gregorieff</surname><given-names>A</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Canonical Wnt signals are essential for homeostasis of the intestinal epithelium</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>1709</fpage><lpage>1713</lpage><pub-id pub-id-type="doi">10.1101/gad.267103</pub-id><pub-id pub-id-type="pmid">12865297</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Wnt control of stem cells and differentiation in the intestinal epithelium</article-title><source>Experimental Cell Research</source><volume>306</volume><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2005.02.022</pub-id><pub-id pub-id-type="pmid">15925592</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramadan</surname><given-names>R</given-names></name><name><surname>van Driel</surname><given-names>MS</given-names></name><name><surname>Vermeulen</surname><given-names>L</given-names></name><name><surname>van Neerven</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Intestinal stem cell dynamics in homeostasis and cancer</article-title><source>Trends in Cancer</source><volume>8</volume><fpage>416</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2022.01.011</pub-id><pub-id pub-id-type="pmid">35153158</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rim</surname><given-names>EY</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The wnt pathway: from signaling mechanisms to synthetic modulators</article-title><source>Annual Review of Biochemistry</source><volume>91</volume><fpage>571</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-040320-103615</pub-id><pub-id pub-id-type="pmid">35303793</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>Snippert</surname><given-names>HJ</given-names></name><name><surname>Stange</surname><given-names>DE</given-names></name><name><surname>Vries</surname><given-names>RG</given-names></name><name><surname>van den Born</surname><given-names>M</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>van de Wetering</surname><given-names>M</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts</article-title><source>Nature</source><volume>469</volume><fpage>415</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1038/nature09637</pub-id><pub-id pub-id-type="pmid">21113151</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>O’Leary</surname><given-names>CE</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Regulation of immune responses by tuft cells</article-title><source>Nature Reviews. Immunology</source><volume>19</volume><fpage>584</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0176-x</pub-id><pub-id pub-id-type="pmid">31114038</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>George</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Super-enhancer-driven transcriptional dependencies in cancer</article-title><source>Trends in Cancer</source><volume>3</volume><fpage>269</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2017.03.006</pub-id><pub-id pub-id-type="pmid">28718439</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoshkes-Carmel</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>YJ</given-names></name><name><surname>Wangensteen</surname><given-names>KJ</given-names></name><name><surname>Tóth</surname><given-names>B</given-names></name><name><surname>Kondo</surname><given-names>A</given-names></name><name><surname>Massasa</surname><given-names>EE</given-names></name><name><surname>Itzkovitz</surname><given-names>S</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Subepithelial telocytes are an important source of Wnts that supports intestinal crypts</article-title><source>Nature</source><volume>557</volume><fpage>242</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0084-4</pub-id><pub-id pub-id-type="pmid">29720649</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snoeck</surname><given-names>V</given-names></name><name><surname>Goddeeris</surname><given-names>B</given-names></name><name><surname>Cox</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The role of enterocytes in the intestinal barrier function and antigen uptake</article-title><source>Microbes and Infection</source><volume>7</volume><fpage>997</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2005.04.003</pub-id><pub-id pub-id-type="pmid">15925533</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>LK</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Preisinger</surname><given-names>AC</given-names></name><name><surname>Moser</surname><given-names>AR</given-names></name><name><surname>Luongo</surname><given-names>C</given-names></name><name><surname>Gould</surname><given-names>KA</given-names></name><name><surname>Dove</surname><given-names>WF</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene</article-title><source>Science</source><volume>256</volume><fpage>668</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1126/science.1350108</pub-id><pub-id pub-id-type="pmid">1350108</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terrin</surname><given-names>L</given-names></name><name><surname>Agostini</surname><given-names>M</given-names></name><name><surname>Ruvoletto</surname><given-names>M</given-names></name><name><surname>Martini</surname><given-names>A</given-names></name><name><surname>Pucciarelli</surname><given-names>S</given-names></name><name><surname>Bedin</surname><given-names>C</given-names></name><name><surname>Nitti</surname><given-names>D</given-names></name><name><surname>Pontisso</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer</article-title><source>Oncotarget</source><volume>8</volume><fpage>15732</fpage><lpage>15743</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.14997</pub-id><pub-id pub-id-type="pmid">28178650</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Biehs</surname><given-names>B</given-names></name><name><surname>Warming</surname><given-names>S</given-names></name><name><surname>Leong</surname><given-names>KG</given-names></name><name><surname>Rangell</surname><given-names>L</given-names></name><name><surname>Klein</surname><given-names>OD</given-names></name><name><surname>de Sauvage</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable</article-title><source>Nature</source><volume>478</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1038/nature10408</pub-id><pub-id pub-id-type="pmid">21927002</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Flier</surname><given-names>LG</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Stem cells, self-renewal, and differentiation in the intestinal epithelium</article-title><source>Annual Review of Physiology</source><volume>71</volume><fpage>241</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1146/annurev.physiol.010908.163145</pub-id><pub-id pub-id-type="pmid">18808327</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>Jay</surname><given-names>P</given-names></name><name><surname>Gregorieff</surname><given-names>A</given-names></name><name><surname>van Gijn</surname><given-names>ME</given-names></name><name><surname>Jonkheer</surname><given-names>S</given-names></name><name><surname>Hatzis</surname><given-names>P</given-names></name><name><surname>Thiele</surname><given-names>A</given-names></name><name><surname>van den Born</surname><given-names>M</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><name><surname>Brabletz</surname><given-names>T</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Wnt signalling induces maturation of Paneth cells in intestinal crypts</article-title><source>Nature Cell Biology</source><volume>7</volume><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/ncb1240</pub-id><pub-id pub-id-type="pmid">15778706</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>van de Wetering</surname><given-names>M</given-names></name><name><surname>Lyubimova</surname><given-names>A</given-names></name><name><surname>Yee Nee</surname><given-names>AN</given-names></name><name><surname>Gregorieff</surname><given-names>A</given-names></name><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Zeinstra</surname><given-names>L</given-names></name><name><surname>van den Born</surname><given-names>M</given-names></name><name><surname>Korving</surname><given-names>J</given-names></name><name><surname>Martens</surname><given-names>ACM</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dll1+ secretory progenitor cells revert to stem cells upon crypt damage</article-title><source>Nature Cell Biology</source><volume>14</volume><fpage>1099</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1038/ncb2581</pub-id><pub-id pub-id-type="pmid">23000963</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>K</given-names></name><name><surname>Huo</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Hua</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>QF</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zeng</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>An epigenetic circuit controls neurogenic programs during neocortex development</article-title><source>Development</source><volume>148</volume><elocation-id>dev199772</elocation-id><pub-id pub-id-type="doi">10.1242/dev.199772</pub-id><pub-id pub-id-type="pmid">35020876</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>K</given-names></name><name><surname>Hua</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A Ctnnb1 enhancer regulates neocortical neurogenesis by controlling the abundance of intermediate progenitors</article-title><source>Cell Discovery</source><volume>8</volume><elocation-id>74</elocation-id><pub-id pub-id-type="doi">10.1038/s41421-022-00421-2</pub-id><pub-id pub-id-type="pmid">35915089</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>ES</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>SZ</given-names></name><name><surname>Bower</surname><given-names>NL</given-names></name><name><surname>Garside</surname><given-names>V</given-names></name><name><surname>Vanwalleghem</surname><given-names>G</given-names></name><name><surname>Gaiti</surname><given-names>F</given-names></name><name><surname>Scott</surname><given-names>E</given-names></name><name><surname>Hogan</surname><given-names>BM</given-names></name><name><surname>Kikuchi</surname><given-names>K</given-names></name><name><surname>McGlinn</surname><given-names>E</given-names></name><name><surname>Francois</surname><given-names>M</given-names></name><name><surname>Degnan</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Deep conservation of the enhancer regulatory code in animals</article-title><source>Science</source><volume>370</volume><elocation-id>eaax8137</elocation-id><pub-id pub-id-type="doi">10.1126/science.aax8137</pub-id><pub-id pub-id-type="pmid">33154111</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Huo</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in <italic>Setd2</italic> mutant mice</article-title><source>Science Advances</source><volume>7</volume><elocation-id>eaba1180</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aba1180</pub-id><pub-id pub-id-type="pmid">33523829</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>KS</given-names></name><name><surname>Chia</surname><given-names>LA</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Ootani</surname><given-names>A</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Su</surname><given-names>N</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Heilshorn</surname><given-names>SC</given-names></name><name><surname>Amieva</surname><given-names>MR</given-names></name><name><surname>Sangiorgi</surname><given-names>E</given-names></name><name><surname>Capecchi</surname><given-names>MR</given-names></name><name><surname>Kuo</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations</article-title><source>PNAS</source><volume>109</volume><fpage>466</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1073/pnas.1118857109</pub-id><pub-id pub-id-type="pmid">22190486</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Ozer</surname><given-names>A</given-names></name><name><surname>Leung</surname><given-names>AKY</given-names></name><name><surname>Lis</surname><given-names>JT</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A comparison of experimental assays and analytical methods for genome-wide identification of active enhancers</article-title><source>Nature Biotechnology</source><volume>40</volume><fpage>1056</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.1038/s41587-022-01211-7</pub-id><pub-id pub-id-type="pmid">35177836</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zabidi</surname><given-names>MA</given-names></name><name><surname>Stark</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulatory enhancer-core-promoter communication via transcription factors and cofactors</article-title><source>Trends in Genetics</source><volume>32</volume><fpage>801</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2016.10.003</pub-id><pub-id pub-id-type="pmid">27816209</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Shi</surname><given-names>XE</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>BAMBI promotes C2C12 myogenic differentiation by enhancing Wnt/β-catenin signaling</article-title><source>International Journal of Molecular Sciences</source><volume>16</volume><fpage>17734</fpage><lpage>17745</lpage><pub-id pub-id-type="doi">10.3390/ijms160817734</pub-id><pub-id pub-id-type="pmid">26247931</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Targeting the Wnt/β-catenin signaling pathway in cancer</article-title><source>Journal of Hematology &amp; Oncology</source><volume>13</volume><elocation-id>165</elocation-id><pub-id pub-id-type="doi">10.1186/s13045-020-00990-3</pub-id><pub-id pub-id-type="pmid">33276800</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Ming</surname><given-names>T</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Tao</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Wnt signaling in colorectal cancer: pathogenic role and therapeutic target</article-title><source>Molecular Cancer</source><volume>21</volume><elocation-id>144</elocation-id><pub-id pub-id-type="doi">10.1186/s12943-022-01616-7</pub-id><pub-id pub-id-type="pmid">35836256</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>G</given-names></name><name><surname>Pang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Higgins</surname><given-names>GA</given-names></name><name><surname>Wiley</surname><given-names>JW</given-names></name><name><surname>Hou</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Glucocorticoid receptor-mediated <italic>Nr1d1</italic> chromatin circadian misalignment in stress-induced irritable bowel syndrome</article-title><source>iScience</source><volume>26</volume><elocation-id>107137</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2023.107137</pub-id><pub-id pub-id-type="pmid">37404374</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Advances of wnt signalling pathway in colorectal cancer</article-title><source>Cells</source><volume>12</volume><elocation-id>447</elocation-id><pub-id pub-id-type="doi">10.3390/cells12030447</pub-id><pub-id pub-id-type="pmid">36766788</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98238.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Palmiter</surname><given-names>Richard D</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Howard Hughes Medical Institute, University of Washington</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>Ctnnb1 encodes β-catenin, an essential component of the canonical Wnt signaling pathway. In this <bold>important</bold> study, the authors identify an upstream enhancer of Ctnnb1 responsible for the specific expression level of β-catenin in the gastrointestinal track. Deletion of this enhancer in mice and analyses of its association with human colorectal tumors provide <bold>compelling</bold> support that it controls the dosage of Wnt signaling critical to the homeostasis in intestinal epithelia and colorectal cancers.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98238.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Ctnnb1 encodes β-catenin, an essential component of the canonical Wnt signaling pathway. In this study, the authors identify an upstream enhancer of Ctnnb1 responsible for the specific expression level of β-catenin in the gastrointestinal track. Deletion of this promoter in mice and analyses of its association with human colorectal tumors support that it controls the dosage of Wnt signaling critical to the homeostasis in intestinal epithelia and colorectal cancers.</p><p>Strengths:</p><p>This study has provided convincing evidence to demonstrate the functions of a gastrointestinal enhancer of Ctnnb1 using combined approaches of bioinformatics, genomics, in vitro cell culture models, mouse genetics, and human genetics. The results support the idea that the dosage of Wnt/β-catenin signaling plays an important role in pathophysiological functions of intestinal epithelia. The experimental designs are solid and the data presented are of high quality. This study significantly contributes to the research fields of Wnt signaling, tissue-specific enhancers, and intestinal homeostasis.</p><p>Weaknesses:</p><p>Insufficient discussion on some findings was a major weakness in the previous submission, which has been addressed in the revised submission.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98238.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Wnt signaling is the name given to a cell-communication mechanism that cells employ to inform on each other's position and identity during development. In cells that receive the Wnt signal from the extracellular environment, intracellular changes are triggered that cause the stabilization and nuclear translocation of β-catenin, a protein that can turn on groups of genes referred to as Wnt targets. Typically these are genes involved in cell proliferation. Genetic mutations that affect Wnt signaling components can therefore affect tissue expansion. Loss of function of APC is a drastic example: APC is part of the β-catenin destruction complex, and in its absence, β-catenin protein is not degraded and constitutively turns on proliferation genes, causing cancers in the colon and rectum. And here lies the importance of the finding: β-catenin has for long been considered to be regulated almost exclusively by tuning its protein turnover. In this article, a new aspect is revealed: Ctnnb1, the gene encoding for β-catenin, possesses tissue-specific regulation with transcriptional enhancers in its vicinity that drive its upregulation in intestinal stem cells. The observation that there is more active β-catenin in colorectal tumors not only because the broken APC cannot degrade it, but also because transcription of the Ctnnb1 gene occurs at higher rates, is novel and potentially game-changing. As genomic regulatory regions can be targeted, one could now envision that mutational approaches aimed at dampening Ctnnb1 transcription could be a viable additional strategy to treat Wnt-driven tumors.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98238.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors of this paper identify an enhancer that upstream of the Ctnnb1 gene that selectively enhances expression in intestinal cells. This enhancer sequence drives expression of a reporter gene in the intestine and knockout of this enhancer attenuates Ctnnb1 expression in the intestine, while protecting mice from intestinal cancers. The human counterpart of this enhancer sequence is functional and involved in tumorigenesis. Overall, this is an excellent example of how to fully characterize a cell-specific enhancer. The strength of the study is the thorough nature of the analysis and the relevance of the data to development of intestinal tumors in both mice and humans. A minor weakness was that that loss of this enhancer does not completely compromise expression of Ctnnb1 gene in the intestine, suggesting that other elements are likely involved. The authors have now addressed this concern.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98238.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hua</surname><given-names>Xiaojiao</given-names></name><role specific-use="author">Author</role><aff><institution>Wuhan University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Chen</given-names></name><role specific-use="author">Author</role><aff><institution>Wuhan University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Jianbo</given-names></name><role specific-use="author">Author</role><aff><institution>Wuhan university</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Junbao</given-names></name><role specific-use="author">Author</role><aff><institution>Wuhan University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Miao</surname><given-names>Xiaoping</given-names></name><role specific-use="author">Author</role><aff><institution>Wuhan University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Gen</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong University of Science and Technology</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Min</given-names></name><role specific-use="author">Author</role><aff><institution>Wuhan University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Mei</given-names></name><role specific-use="author">Author</role><aff><institution>Zhongnan Hospital of Wuhan University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Ying</given-names></name><role specific-use="author">Author</role><aff><institution>Wuhan University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Yan</given-names></name><role specific-use="author">Author</role><aff><institution>Wuhan University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1:</bold></p><p>(1) One issue that needs to be considered is the nomenclature of the enhancer. The authors have presented data to show this enhancer controls the expression of Ctnnb1 in the stomach, intestine, and colon tissues. However, the name proposed by the authors, ieCtnnb1 (intestinal enhancer of Ctnnb1), doesn't represent its functions. It might be more appropriate to call it a different name, such as gieCtnnb1 (gastrointestinal enhancer of Ctnnb1).</p></disp-quote><p>We thank the reviewer for the insightful suggestion and agree that wholemount reporter assays indicated ieCtnnb1 and ieCTNNB1 indeed display activity in the stomach. However, in current study, we focused on the cellular distribution and the function in intestinal epithelia. After careful consideration, we reasoned that the current designation, ieCtnnb1, would be more appropriately represent its expression pattern and functions based on provided evidence. We hope the reviewer could understand our reasoning.</p><disp-quote content-type="editor-comment"><p>(2) The writing of this manuscript can be improved in a few places.</p><p>a) The definitions or full names for the abbreviations of some terms, e.g., Ctnnb1, ieCtnnb1, in both abstract and main text, are needed when they first appear. Specifically, Line 108 should be moved to Lines 26 and 95. Lines 125126 are redundant. ieCtnnb1 in Line 130 needs to be defined.</p></disp-quote><p>We appreciate the suggestion. In the revision, we have included the definition of Ctnnb1 and the full name of ieCtnnb1 when they first appear in the abstract and the main text. Lines 125-126 were deleted in the revision.</p><disp-quote content-type="editor-comment"><p>b) Line 192-194, the description of the result needs to be rewritten to reflect</p></disp-quote><p>the higher expression of LacZ transcript in eGFP+ cells.</p><p>We would like to emphasize that the key point of this part is that the enhancer activity of ieCtnnb1 is present in both Lgr5-eGFP+ and Lgr5-eGFP- cells. This was validated by single-cell sequencing, which revealed the presence of LacZ transcripts in the Paneth cells. Moreover, we could not confidently conclude that eGFP+ cells have higher expression levels of LacZ, as these measurements were obtained from separate, semi-quantitative RT-qPCR experiments.</p><disp-quote content-type="editor-comment"><p>c) More details are needed for how the data using human tumor samples were generated and how they were analyzed.</p></disp-quote><p>We thank the suggestion. In the revision, we have provided additional details regarding the data and subsequent analyses of human CRC samples as follows: ‘We previously conducted paired analyses of chromatin immunoprecipitation sequencing (ChIP-seq) for H3K27ac and H3K4me3, alongside RNA-seq on 68 CRC samples and their adjacent normal (native) tissue (Li et al., 2021). In the current study, we performed analyses for the enrichment of H3K27ac and H3K4me3 at ieCTNNB1 and CTNNB1 promoter regions, as well as the expression levels of CTNNB1, followed by combined analyses (Figure. 5A, Figure 5 - figure supplement 1).’</p><disp-quote content-type="editor-comment"><p>d) The genomic structures from multiple species are presented at the bottom of Figure 1a. However, the description and explanation are lacking in both the main text and the figure legend.</p></disp-quote><p>We apologize for not presenting clearly. We have added related description in the legend of Figure 1A as ‘The sequence conservation of the indicated species is shown at the bottom as vertical lines’. We also added an explanation in lines 162-163 of the main text: ‘Notably, unlike neCtnnb1, the primary sequence of ieCtnnb1 is not conserved among vertebrates (Figure 1A, bottom)’.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2:</bold></p><p>(1) One of the main issues emerging during reading concerns the interpretation of the consequence of deleting the ieCtnnb1 enhancer. The authors write on line 235 that the deletion of ieCtnnb1 ‘undermined’ Wnt signaling in the intestinal epithelium. This feels too strong, as the status of the pathway is only mildly affected, testified by the observation that mice with homozygous deletion on ieCtnnb1 are alive and well. The enhancer likely ‘only’ drives higher Ctnnb1 expression, and it does not affect Wnt signaling by other mechanisms. The reduction of Wnt target gene expression upon its deletion is easily interpreted as the consequence of reduced β-catenin. Also the title, in my opinion, allows this ambiguity to stick in readers' minds. In other words, the authors present no evidence that the ieCtnnb1 enhancer controls Wnt signaling dosage via any mechanism other than its upregulation of Ctnnb1 expression in the intestinal epithelium. Reduced Ctnnb1, in turn, could explain the observed reduction of Wnt signaling output and the interesting downstream physiological consequences. Unless the authors think otherwise, I suggest they clarify this throughout the text, including necessary modifications to the title.</p></disp-quote><p>We greatly appreciate the reviewer’s important comments and suggestion. We agree that ieCtnnb1’s direct effect on the canonical Wnt signaling is to regulate the transcription of Ctnnb1 in the intestinal epithelia. Therefore, knockout of ieCtnnb1 leads to compromised expression of Ctnnb1 and, consequently, reduced Wnt signaling. The term ‘undermined’ is indeed too strong and has been revised to ‘compromised’ in the revision (line 237). Similar revisions have been made throughout the manuscript. Particularly, the title was changed into ‘A Ctnnb1 enhancer transcriptionally regulates Wnt signaling dosage to balance homeostasis and tumorigenesis of intestinal epithelia’. However, as we state in the following point, decreased levels of β-catenin on ieCtnnb1 loss could lead to indirect effect, including the reduced expression of Bambi, which might cause a more significant decrease of nuclear β-catenin.</p><disp-quote content-type="editor-comment"><p>(2) It is unclear how the reduction of Ctnnb1 mRNA caused by deletion of ieCtnnb1 in mice could lead to a preferential decrease of nuclear more than membranous β-catenin (Fig. 1K and L). This might reflect a general cell autonomous reduction in Wnt signaling activation; yet, it is not clear how this could occur. Do the authors have any explanations for this?</p></disp-quote><p>It's a very important question. We observed that in inCtnnb1 knockout epithelia, the expression of Bambi (BMP and activin membrane-bound inhibitor) was significantly downregulated. Since BAMBI has been reported to stabilize β-catenin and facilitate its nuclear translocation, it is likely that the reduced level of BAMBI resulting from the loss of ieCtnnb1 further decreased nuclear βcatenin. In the revision, the expression change of Bambi has been added in Figure 1M. Moreover, the related content was extensively discussed with proper citations: “We noticed that after knocking out ieCtnnb1, the level of βcatenin in the nuclei of small intestinal crypt cells of Ctnnb1Δi.enh mice decreased more significantly compared to that in the cytoplasm (49.5% vs. 29.8%). Although the loss of ieCtnnb1 should not directly lead to reduced nuclear translocation of β-catenin, RNA-seq results showed that the loss of ieCtnnb1 causes a reduction in the expression of Bambi (BMP and activin membranebound inhibitor), a target gene in the canonical Wnt signaling pathway (Figure 1M). BAMBI promotes the binding of Frizzled to Dishevelled, thereby stabilizing β-catenin and facilitating its nuclear translocation (Lin et al., 2008; Liu et al., 2014; Mai et al., 2014; Zhang et al., 2015). Thus, it is likely that the decreased level of BAMBI resulting from the loss of ieCtnnb1 further reduced nuclear βcatenin”.</p><disp-quote content-type="editor-comment"><p>(3) In Figure 1 K-L the authors show β-catenin protein level. Why not show its mRNA?</p></disp-quote><p>The mRNA levels of Ctnnb1 in small and large intestinal crypts were shown in Figure 1I and 1J, demonstrating reduced expression of Ctnnb1 upon ieCtnnb1 knockout. We hope the reviewer understands that it is unnecessary to measure the nuclear and cytosolic levels of Ctnnb1 transcripts, as the total mRNA level generally reflects the protein level.</p><disp-quote content-type="editor-comment"><p>(4) Concerning the GSEA of Figure 1 that includes the Wnt pathway components: (a) it would be interesting to see which components and to what extent is their expression affected; (b) why should the expression of Wnt components that are not Wnt target genes be affected in the first place? It is odd to see this described uncritically and used to support the idea of downregulated Wnt signaling.</p></disp-quote><p>We appreciate the suggestion and apologize for any lack of clarity. The affected components of the Wnt signaling pathway and the extent of their changes are summarized in Figure 1 – figure supplement 3. Additionally, we have provided explanations for their downregulation. For instance, the reduced expression of Wnt3 and Wnt2b ligands in ieCtnnb1-KO crypts may be attributed to the decreased numbers of Paneth cells.</p><disp-quote content-type="editor-comment"><p>(5) In lines 251-252 the authors refer to &quot;certain technical issues&quot; in the isolation of cell type from the intestinal epithelium. Why this part should be obscure in the characterization of a tissue for which there are several established protocols of isolation and analysis is not clear. I would rather describe what these issues have been and how they protocol of isolation and analysis is not clear. I would rather describe what these issues have been and how they might have affected the data presented.</p></disp-quote><p>We thank the reviewer for pointing this out. The single-cell preparation and sequencing of small intestinal cryptal epithelial cells were carried out largely according to reported protocols with slight modification. The enrichment of live crypt epithelial cells (EpCAM+DAPI-) by flow cytometry and cell filtering after single-cell sequencing were appropriate (Figure 2 – figure supplement 1A1C). We would like to emphasize a few points: (1) Unlike other protocols, we did not exclude immune cells, erythrocytes, or endothelial cells using negative sorting antibodies. (2) When defining cell populations, we focused exclusively on epithelial cell types and did not consider other cell types, such as immune cells. As a result, the so-called “undefined” cells include a mixture of nonepithelial cells. Indeed, markers for erythrocytes (AY036118/Erf1, PMID:12894589) and immune cells (Gm42418 and Lars2, PMID:30940803, PMID: 35659337) were the top three enriched genes in the “undefined” cluster (Figure 2 – figure supplement 1D). (3) Nonetheless, the overall findings remain robust, as key observations such as the loss of Paneth cells and reduced cell proliferation were validated through histological studies. This information has been incorporated into the revised manuscript with related references cited (lines 254-259).</p><disp-quote content-type="editor-comment"><p>(6) It is interesting that human SNPs exist that seem to fall within the ieCTNNB1 enhancer and affect the gastrointestinal expression of CTNNB1. Could the author report or investigate whether this SNP is present in human populations that have been considered in large-scale studies for colorectal cancer susceptibility? It seems to me a rather obvious next step of extreme importance to be ignored.</p><p>(7) From Figure 5A a reader could conclude that colorectal tumor cells have a higher expression of CTNNB1 mRNA than in normal epithelium. This is the first time I have seen this observation which somewhat undermines our general understanding of Wnt-induced carcinogenesis exclusively initiated by APC mutations whereby it is β-catenin's protein level, not expression of its mRNA, of crucial importance. I find this to be potentially the most interesting observation of the current study, which could be linked to the activity of the enhancer discovered, and I suggest the authors elaborate more on this and perhaps consider it for future experimental follow-ups.</p></disp-quote><p>We appreciate the comments and suggestions. We therefore added related content in the revision (lines 470-475): “Importantly, ieCTNNB1 displayed higher enhancer activity in most CRC samples collected in the study. Moreover, the SNP rs15981379 (C&gt;T) within ieCTNNB1 is associated with the expression of CTNNB1 in the GI tract. Future population studies could investigate how the enhancer activity of ieCTNNB1 and this particular SNP are associated with CRC susceptibility and prognosis”.</p><disp-quote content-type="editor-comment"><p>(8) I am surprised that the authors, who seem to have dedicated lots of resources to this study, are satisfied by analyzing their ChIP experiments with qPCR rather than sequencing (Figure 6). ChIP-seq would produce a more reliable profile of the HNF4a and CREB1 binding sites on these loci and in other control regions, lending credibility to the whole experiment and binding site identification. Sequencing would also take care of the two following conceptual problems in primer design.</p><p>First: while the strategy to divide enhancer and promoter in 6 regions to improve the resolution of their finding is commendable, I wonder how the difference in signal reflects primers' efficiency rather than HNF4/CREB1 exact positioning. The possibility of distinguishing between regions 2 and 3, for example, in a ChIP-qPCR experiment, also depends on the average DNA fragment length after sonication, a parameter that is not specified here.</p><p>Second: what are the primers designed to detect the ieCtnnb1 enhancer amplifying in the yellow-columns samples of Figure 6G? In this sample, the enhancer is deleted, and no amplification should be possible, yet it seems that a value is obtained and set to 1 as a reference value.</p></disp-quote><p>This is indeed a crucial point, and we fully agree with the reviewer that “ChIP-seq would produce a more reliable profile of the HNF4a and CREB1 binding sites on these loci and in other control regions”. However, we believe that our current ChIP-qPCR experiments have adequately addressed the potential concerns raised by the reviewers. (1) We have ensured that the DNA fragment length after sonication falls within the range of 200 bp to 500 bp, with an average length of approximately 300 bp (Author response image 1A). We have stated the point in the revised methods section (line 633). (2) We have randomly inspected 14 out of 26 primer sets used in Figure 6 and its supplemental figure (Author response image 1B-E), confirming that all primer sets demonstrate equal amplification efficiency (ranging from 90% to 110%). This information has also been included in the revised methods section (line 650). (3) Figures 6G and 6H show reduced enrichment of HNF4𝛼 (6G) and p-S133-CREB1 (6H) at the Ctnnb1 promoter in ieCtnnb1 knockout ApcMin/+ tumor tissues. The ChIP-qPCR primers used were positioned at the Ctnnb1 promoter, not at ieCtnnb1, with IgG control enrichment serving as the reference values on the Y-axes.</p><fig id="sa4fig1" position="float"><label>Author response image 1.</label><caption><title>Quality control assays for ChIP-qPCR.</title><p>(A) Agarose gel electrophoresis of sonicated DNA. (B-E) Tests of amplification efficiency for primer sets used in ChIP-qPCR.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98238-sa4-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>(9) The ChIP-qPCR showing preferential binding of pS133-CREB1 in small intestinal crypts and CHT15 cells (line 393) should be shown.</p></disp-quote><p>The ChIP-qPCR results demonstrating preferential binding of p-S133-</p><p>CREB1 over CREB1 have been added in revised Figure 6C, 6D and Figure 6 – Supplement 1C.</p><disp-quote content-type="editor-comment"><p>(10) It is not entirely clear what the blue tracks represent at the bottom of Figures 6C-D and Figure 6 - Figure Supplement 1C-D. The ChIP-seq profiles of both CREB1 and HNF4a shown in Figures 6A and Figure 6 - Figure Supplement 1A do not seem to match. Taking HNF4a, for example from Figure 6 - Figure Supplement 1A it seems to bind on the Ctnnb1 promoter, while in Figure 6 - Figure Supplement 1D the peaks are within the first intron. I realize this might all be a problem with a different scale across figure panels, but I suggest producing a cleared figure.</p></disp-quote><p>We apologize for the confusion. We have revised Figure 6C-6D, Figure 6 - figure supplement 1C-D, and the corresponding legends to enhance clarity. (1) The top panels of Figures 6C and 6D respectively highlight shaded regions of ieCTNNB1 (pink) and the CTNNB1 promoter (grey) in Figure 6A, emphasizing the enrichment of p-S133-CREB1. (2) The top panels of Figure 6 – figure supplement 1C and 1D respectively highlight shaded regions of ieCtnnb1 (pink) and the Ctnnb1 promoter (grey) in Figure 6A – figure supplement 1A, emphasizing the enrichment of HNF4α. (3) Because Figures 6C-6D and Figure 6 - figure supplement 1C-1D respectively correspond to human and mouse genomes, the positions of peaks and scales differ.</p><disp-quote content-type="editor-comment"><p>(11) In the intro the authors refer to &quot;TCF-4&quot;. I suggest they use the more recent unambiguous nomenclature for this family of transcription factors and call it TCF7L2.</p></disp-quote><p>TCF-4 has been changed into TCF7L2 in the revision (line 81)</p><disp-quote content-type="editor-comment"><p>(12) In lines 121-122, the authors write &quot;Although numerous putative enhancers...only a fraction of them were functionally annotated&quot;. To what study/studies are the authors referring? Please provide references.</p></disp-quote><p>References were added in the revision (line 124)</p><disp-quote content-type="editor-comment"><p>(13) In some parts the authors use strong words that should in my opinion be attenuated. Examples are: (i) at line 224, &quot;maintains&quot; would be better substituted with &quot;contribute&quot;, as in the absence of ieCtnnb1, Ctnnb1 is still abundantly expressed; (ii) at line 266 &quot;compromised&quot; when the proliferative capacity of CFCs and TACs seems to be only mildly reduced; (iii) at line 286 &quot;disrupts&quot;, the genes are simply downregulated.</p></disp-quote><p>We thank these great suggestions. (1) On lines 224-225, the sentence was revised to: “These data suggest that ieCtnnb1 plays a specific role in regulating the transcription of Ctnnb1 in intestinal epithelia”. (2) On line 271, “compromised” were replaced with “mildly reduced”. (3) In ieCtnnb1 knockout epithelial cells of small intestine, genes related to secretory functions were decreased, while genes related to absorptive functions were increased. Therefore, the term 'disrupts' is more appropriate than 'downregulates'.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3:</bold></p><p>Line 81, c-Myc should be human MYC (italics) to agree with the other human gene names in this sentence.</p></disp-quote><p>c-Myc has been changed into MYC in the revision (line 82)</p><disp-quote content-type="editor-comment"><p>Line 215, wildtype should be wild-type.</p></disp-quote><p>“wildtype” has been changed into “wild-type” in the revision (line 215)</p><disp-quote content-type="editor-comment"><p>Line 224, Elimination of the enhancer did not abolish expression of Ctnnb1; therefore, it would be better to say that it &quot;helps to maintain Ctnnb1 transcription&quot;</p></disp-quote><p>The sentence was changed into “These data suggest that ieCtnnb1 plays a specific role in regulating the transcription of Ctnnb1 in intestinal epithelia” in revision (lines 224-225)</p><disp-quote content-type="editor-comment"><p>Line 228, perhaps &quot;to activate transcription&quot; is meant.</p></disp-quote><p>“active” has been changed into “activate” in the revision (line 228)</p><disp-quote content-type="editor-comment"><p>Line 235, consider &quot;reduced&quot; instead of &quot;undermined&quot;.</p></disp-quote><p>“undermined” has been replaced with “compromised” in the revision (line 237)</p><disp-quote content-type="editor-comment"><p>Line 262, &quot;em&quot; dashes should be a both ends of this insertion.</p><p>Line 298, &quot;dysfunctional&quot; would be better.</p><p>Line 356, &quot;samples were&quot;.</p><p>Line 481, 12-hr (add hyphen).</p></disp-quote><p>All above points have been optimized according to the reviewer’s suggestion.</p><disp-quote content-type="editor-comment"><p>Line 712, Is &quot;poly-N&quot; meant?</p></disp-quote><p>“Poly-N” indicates undetected bases during sequencing. This explanation was added in the revision (lines 759-760).</p><disp-quote content-type="editor-comment"><p>Figure 1K, the GAPDH signal is not visible and that panel is unnecessary as there is an H3 control.</p></disp-quote><p>Figure 1K and 1L respectively show levels of nuclear and cytoplasmic βcatenin. GAPDH and H3 were used as internal references for the cytoplasmic and nuclear fractions, respectively, confirming both robust fractionation and equal loading.</p></body></sub-article></article>